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G eneral  intro duc tion 
and objec tives
Much has been written on perforated peptic ulcer (PPU) during the last hundred years. 
In 1500, when necropsies were !rst allowed, often a small hole was found in the 
anterior wall of the stomach, giving an explanation for symptoms of acute abdominal 
pain, nausea, vomiting which often led to death within a few hours or days. 
Laparoscopic surgery, also called minimal invasive surgery or keyhole surgery is a 
surgical technique in which operations are performed through small incisions as 
compared to the larger incision needed in traditional surgical procedures. Georg 
Kelling performed the !rst laparoscopic procedure in dogs in 1902 and in 1910 Hans 
Christian Jacobaeus was responsible for the !rst laparoscopic procedure in humans, 
but it took till the 80s of the last century before laparoscopic procedures became 
popular. Bene!ts of laparoscopic surgery are less postoperative pain, minimal scarring 
and lower morbidity and mortality. A review of the history of perforated peptic ulcer 
disease (PUD) has been written in chapter 1 and a review on laparoscopic correction 
for PPU has been written in Chapter 2. The aim of this thesis was to demonstrate if 
laparoscopic correction of PPU was feasible and if it was superior to the routine 
correction of PPU by upper laparotomy. For this a Dutch multicenter trial, the LAMA 
trial, was performed. During this trial several questions raised, which led to more 
research.  First of all, reviewing literature on this topic, it became clear that consensus 
on several topics was lacking (Chapter 3, 4). A European questionnaire was sent to get 
an impression of the current preferred methods of choice (Chapter 5). During the 
LAMA trial it was discovered that the laparoscopic suture procedure sometimes led to 
problems. Therefore an alternative technique for closure of the perforation without 
the need for suturing was tested in rats (Chapter 6 and 7). Finally, during surgery for 
PPU routinely a biopsy is taken for testing on Helicobacter pylori (H.pylori), one of the 
main causes for the occurrence of peptic ulcer disease.  It was questioned if testing 
the abdominal "uid or serum could replace the need for a biopsy, but also it was 
evaluated if there was one genetic type of the H.pylori responsible for the emergence 
of PPU, which could be an important factor in the prevention of PPU (Chapter 8).
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Per forated Peptic  Ulcer  disease:
A review of  histor y and treatment
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Abstract  
In the last hundred years much has been written on peptic ulcer disease and the 
treatment options for one of its most common complications: perforation. The reason 
for reviewing literature was evaluating most common ideas on how to treat perforated 
peptic ulcers in general, opinions on conservative treatment and surgical treatment 
and summarizing ideas about necessary pre- per and postoperative proceedings . For 
this all relevant articles found by medline, ovid and pubmed search were used. 
History
For thousands of years healthy people have had 
acute abdominal pain, nausea, vomiting and 
diarrhoea followed by death in a few hours or days. 
Often these symptoms were contributed to 
poisoning and people have been sent to prison for 
this [1]. King Charles I’s daughter, Henriette-Anne, 
died suddenly in 1670 (at age 26) after a day of 
abdominal pain and tenderness. Since poisoning 
was suspected autopsy was performed and revealing 
peritonitis and a small hole in the anterior wall of the 
stomach. However, the doctors had never heard of a perforated peptic ulcer (PPU) and 
attributed the hole in the stomach to the knife of the dissector [1, 2]. Necropsies were 
!rst allowed since 1500 and became more routine between 1600 and 1800 [2, 3]. As a 
consequence more often perforation of the stomach was observed. Johan Mikulicz-
Radecki (1850-1905), often referred to as the !rst surgeon who closed a perforated 
peptic ulcer (PPU) by simple closure said: “ Every doctor, faced with a perforated 
duodenal ulcer of the stomach or intestine, must consider opening the abdomen, 
sewing up the hole, and averting a possible in"ammation by careful cleansing of the 
abdominal cavity” [4].  Surprising enough treatment since has not changed much, still 
consisting of primary closure of the perforation by single stitch suture and a convenient 
tag of adjacent omentum on top of this [5-8]. Although this therapy sounds very 
simple still PPU remains a dangerous surgical condition, associated with high 
morbidity and mortality, not to be underestimated [9]. 
Henriette-Anne
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Clinical presentation and investigation
In 1843 Edward Crisp was the !rst to  report 50 cases of PPU and accurately summarized 
the clinical aspects of perforation; concluding: “The symptoms are so typical, I hardly 
believe it possible that anyone can fail to make the correct diagnosis.” [10]. Patients 
with PPU have a typical history of sudden onset of acute, sharp pain usually located in 
the epigastric area and sometimes with referred shoulder pain, indicating free air 
under the diaphragm [11].  Bases on collected data from 52 papers on PPU clinical 
characteristics have been summarized in table 1. The typical patient with PPU is male 
with an average age of 48 years. He may have a history of peptic ulcer disease (29%), 
or nonsteroidal anti-in"ammatory drugs (NSAIDs) usage (20%). Vomiting and nausea 
are present in 50% of cases. At physical examination pulse might be quickened, but 
seldom goes beyond 90 beats per minute. About 5-10% of patients experience shock 
with a mean arterial pressure of less than 80 mmHg [12]. Hypotension is a late !nding 
as is a high fever. Obliteration or complete absence of liver dullness was only noted in 
37%, so as a diagnostic tool, this has its limitations [7]. In blood analysis a moderate 
leucocytoses will be found. Main reason for taking a blood sample is excluding other 
diagnosis like for instance pancreatitis [4]. An X-ray of the abdomen/thorax in standing 
position will reveal free air under diaphragm in about 80-85 % [7, 13]. Some centres 
perform abdominal ultrasonography, or computerized tomography (CT) scans with 
oral contrast [14]. With current radiological techniques 80-90% of cases are correctly 
diagnosed [12]. As soon as diagnosis is made resuscitation is started with large volume 
crystalloids, nasogastric suction to empty the stomach; and administration of broad-
spectrum antibiotics [13, 15].  When PPU has been diagnosed, there are a few di#erent 
therapeutic options to be taken into consideration [12]. First of all it must be evaluated 
if the patients is suitable  for surgery or should conservative treatment be considered 
instead. If surgery is indicated, is simple closure with or without omentoplasty 
su$cient or is there a need for de!nitive ulcer surgery and if there is a need for 
de!nitive surgery, which speci!c operation is indicated? Finally, can the operation be 
performed laparoscopically or are there risk factors that would made laparotomy a 
safer option? [12, 16].
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Pathogenesis
The pathogenesis of  PUD may best be considered as representing a complex scenario 
involving an imbalance between defensive (mucus-bicarbonate layer, prostaglandins, 
cellular renovation, and blood "ow) and aggressive factors (hydrochloric acid, pepsin, 
ethanol, bile salts, some medications, etc.) [15]. In recent years Helicobacter pylori 
(H.pylori) infection and NSAIDs have been identi!ed as the two main causes of peptic 
ulcer.[17]. The use of crack cocaine has also led to an increase in PPU, but with a 
di#erent underlying mechanism since PPU secondary to the use of crack cocaine is 
  Total  n=2784
Age (years) 48 n=2328
Male (%) 79 n=2678
History of ulcer (%) 29 n=1140
History of NSAID use (%) 20 n=1109
Smokers (%) 62 n=472
Alcohol use (%) 29 n=198
ASA I (%) 35 n=1120
ASA II (%) 37 n=1060
ASA III (%) 20 n=1060
ASA IV (%) 9 n=1030
Boey 0 (%) 59 n=513
Boey 1 (%) 23 n=513
Boey 2 (%) 16 n=513
Boey 3 (%) 2 n=513
Shock at admission (%) 7 n=1107
Symptoms > 24 hrs (%) 11 n=723
Duration of symptoms (hrs) 13.6 n=837
Free air on x-ray (%) 85 n=510
WBC 12.3 n=147
Table 1. Demographics of patients with perforated peptic ulcer disease 
[12, 13, 16, 31, 41-43, 45, 49, 51, 52, 58-87], [88-100]
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caused by ischemia of the gastric mucosa and treatment of these perforations do not 
require acid reducing de!nitive surgery [12]. Three clinical phases in the process of 
PPU can be distinguished [4].  Phase 1: Chemical peritonitis/ contamination: The 
perforation causes a chemical peritonitis. Acid sterilizes gastroduodenal contents; it is 
only when gastric acid is reduced by treatment or disease (gastric cancer) that bacteria 
and fungi are present in the stomach and duodenum. Phase 2: Intermediate stage: 
after 6-12 hrs many patients obtain some spontaneous relief of the pain. This is 
probably due to the dilution of the irritating gastroduodenal contents by ensuing 
peritoneal exudates. Phase 3: Intra-abdominal infection: after 12-24 hrs intra-
abdominal infection supervenes. 
Epidemiology
Perforation occurs in 2-10% of patients with PUD and accounts for more than 70% of 
deaths associated with PUD. Often perforation is the !rst clinical presentation of PUD 
[18]. The incidence of duodenal perforation is 7-10 cases/ 100.000 adults per year. [9, 
15, 16, 19-22].  The perforation site usually involves the anterior wall of the duodenum 
(60%), although it might occur antral (20%) and lesser-curvature gastric ulcers (20%)
[19]. Duodenal ulcer is the predominant lesion of the western population, whereas 
gastric ulcers are more frequent in oriental countries, particularly in Japan. Gastric ulcers 
have a higher associated mortality and a greater morbidity resulting from haemorrhage, 
perforation and obstruction [17]. PPU used to be a disorder mainly of younger patients 
(predominantly males), but recently the age of PPU patients is increasing (predominantly 
females)  [16, 20].  Current peak age is 40-60 years [16]. The need for surgery for PPU has 
remained stable or even increased and the mortality of peptic ulcer surgery have not 
decreased since the introduction of H2 receptor antagonists and peptic ulcers are still 
responsible for about 20.000-30.000 deaths per year in Europe [19, 23]. This may be due 
to an increase in use of aspirin and/ or NSAID’s [12].
The role of Helicobacter pylori
Until the discovery of the role of H.pylori in gastric and peptic ulcers by Barry J 
Marshall and Robin Warren in 1982, stress and life style factors were believed to be the 
most important factor contributing to PUD and PPU [24]. In more than 90% of 
duodenal ulcers and up to 80% of gastric ulcers H.pylori infection can be hold 
responsible [17, 24]. H.pylori infection and the accompanying in"ammation disrupts 
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the inhibitory control of gastrin 
release by decreasing antral 
somatostatin, and this is more 
marked if the infecting organism 
is a cagA-positive strain [19]. The 
resulting increase in gastrine 
release and gastric acid secretion 
is a key mechanism by which the 
H.pylori infection induces PUD 
[19]. In most instances infection 
with H.pylori seems to be acquired 
in early childhood. In contrast to many other infections, the immune system does not 
contribute to the healing. [3, 17]. Another problem with eradicating H.pylori is that it 
is not only located on the surface of the gastric mucosa but also in the layer of mucus 
protecting it. In 1994 the national institutes of Health Consensus Development Panel 
on Helicobacter pylori in PUD recommended that ulcer patients positive for H.pylori 
should be treated with antimicrobial agents [25]. The type, number of drugs given 
and treatment duration di#er enormously [25]. Although the problem of antibiotic 
resistance of H.pylori is increasing, combination therapies such as metronidazole with 
clindamycin or metronidazol with tetracycline can achieve eradication rates of 80% or 
more [19, 26].  According to the Maastricht III consensus report !rst line treatment for 
H.pylori infection should be triple therapy which should compromise a proton pump 
inhibitor (PPI) plus clarithromycin plus amoxicillin or metronidazol [17, 27]. 
Monotherapy by just giving antibiotics has proven not to be successful (<30% 
eradication rate) [17].  Traditionally, peptic ulcer is diagnosed endoscopically, but this 
is an expensive tool and not well tolerated by patients [22]. Carbon 13-urea breath 
test is expensive, but represents a reliable indicator of H.pylori infection. The preferred 
method to diagnose H.pylori is by taking peroperative biopsies [22]. Even in patients 
with PPU and NSAID usage, it is advisable to look for the presence of H.pylori, since it 
can be eradicated easily.  To avoid missing gastric cancer, gastroendoscopy should be 
performed in patients > 45 yrs with alarming features like weight loss, anaemia, or 
dysphagia [17].
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Current management PPU
a. Non operative management  Conservative treatment is known as the Taylor 
method and consists of nasogastric aspiration, antibiotics, intravenous "uids and 
nowadays H.pylori triple therapy [23, 26]. In 1946 Taylor presented the !rst series of 
successfully outcome of conservatively treated patients with PPU, based on the theory 
that e#ective gastric decompression and continuous drainage will enhance self-
healing [9],[26]. The fundamental idea for conservative treatment came from Crisp 
who in 1843 noted that perforations of the stomach were !lled up by adhesions to the 
surrounding viscera which prevented leakage from the stomach  into the peritoneum 
[26]. Since, many reports have been published on this topic, with di#erent success 
rates [9]. But still there is an ongoing debate whether PPU generally needs to be 
operated on or not. It has been estimated that about 40-80% of the perforations will 
seal spontaneously and overall morbidity and mortality are comparable [19, 23, 26, 
28]. However, delaying the time point of operation beyond 12h after the onset of 
clinical symptoms will worsen the outcome in PPU [9, 19]. Also in patients > 70 years 
conservative treatment is  unsuccessful with a failure rate as high as 67% [9, 28]. Shock 
at admission and conservative treatment were associated with a high mortality rate 
(64%) [9, 23]. Patients likely to respond well to conservative treatment can be selected 
by  performing a gastroduodenogram as described by Donovan.[26]. Non surgical 
treatment in these patients, who had proven sealing of their perforation site was safe, 
only resulted in  3% intraabdominal abscess formation and < 2% repeat leak [26].  The 
advantages of conservative treatment are avoidance of operation with associated 
morbidity caused by surgery and anesthesia, reduction in formation of intra-
abdominal adhesion induced by surgery which makes elective surgery for PUD or for 
other indications in a later phase less complicated and hospital stay might be shorter 
[29]. However,  there are also studies that showed a prolonged hospital stay after 
conservative treatment [13, 19]. Disadvantages are a higher mortality rate in case 
conservative treatment fails. Another disadvantage is the lack of the bene!t of 
laparoscopy or laparotomy as a diagnostic tool in case the patient was misdiagnosed.
[28, 29]. Finally one always has to bear in mind that PPU can be a symptom of gastric 
cancer, so if conservative treatment has been chosen after a few weeks endoscopy 
should be performed [9, 28]. For conclusion one can say that non operative treatment 
is limited to patients < 70 years, not eligible for surgical repair due to associated 
morbidity, with documented contrast studies showing that the perforation has 
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completely sealed. When the patients is in shock or is the time point between 
perforation and “start treatment” > 12 hours simple closure should be !rst choice of 
treatment.
b. Simple suture Open repair technique: All surgical procedures start by giving 
prophylactic antibiotics at induction of anesthesia. In conventional surgery an upper 
midline incision is performed. Identi!cation of the site of perforation is not always 
easy: sometimes a perforation has occurred at the dorsal site of the stomach, only to 
be detected afer opening of the lesser sac through the gastrocolic ligament. Also 
double perforations can occur. In case of a gastric ulcer a biopsy is taken to exclude 
gastric cancer. Simple closure of the perforation can be done in di#erent ways 
(!gure 1) : simple closure of the perforation by interrupted sutures without omento-
plasty or (free) omental patch, simple closure of the perforation with a pedicled 
omentum sutured on top of the repair, respresenting omentoplasty, a pedicled 
omental plug drawn into the perforation after which the sutures are tied over it and 
!nally the free omental patch after Graham. The repair can be tested by either !lling 
the abdomen with warm saline and in"ating some air into the nasogastric tube. If no 
bubbles appear, the perforation has been sealed appropriate. Also dye can be injected 
through the nasogastric tube [30]. Thorough peritoneal toilet followed is then 
performed. A drain is not routinely left [31]. The abdominal wound can be in!ltrated 
with bupivacaine 0.25% at the end of the procedure. 
Omentoplasty or omental patch: necessary or 
not?  Cellan-Jones published an article in 1929 
entitled “a rapid method of treatment in 
perforated duodenal ulcers”. Treatment of choice 
at that time was, after excision of friable edges if 
indicated, the application of purse string sutures 
and on top an omental graft [32]. An encountered 
problem was narrowing of the duodenum.  To 
avoid this, he suggested omentoplasty without 
primary closing of the defect. His technique 
consisted of placing 4-6 sutures, selecting a long 
omental strand passing a  !ne suture through it, 
Cellan Jones
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Figure 1: Di!erent suture techniques for closing perforation
Primary closure by interrupted 
sutures
Primary closure by interrupted 
sutured covered with pedicled 
omentoplasty
Cellan-Jones repair: plugging 
the perforation with pedicled 
omentoplasty
Graham patch: plugging the 
perforation with free omental plug
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the tip of the strand is then anchored in the region of the perforation and !nally the 
sutures are tied o# [32]. It was not until 1937 that Graham published his results with a 
free omental graft [33].  He placed three sutures with a piece of free omentum laid 
over these sutures, which are then tied.  No attempt is made to actually close the 
perforation [33]. The omental graft provides the stimulus for !brin formation. His 
approach has been the golden standard since [34]. Very often  surgeons mention they 
used a Graham patch, but they actually mean they used the pedicled omental patch 
described by Cellan-Jones [33].  Schein could not have outlined it any clearer: “Do not 
stitch the perforation but plug it with viable omentum and patch a perforated ulcer if 
you can, if you cannot, then you must resect” [4].
Irrigation of the peritoneal cavity  Although some surgeons doubt the usefulness of 
irrigation, nothing has been found in literature supporting this theory. General it is 
re"ected on to be one of the most important parts of the surgery and irrigation with 
6-10 litres and even up to 30 litres of warm saline are recommended [16].  However 
the rational for routinely use of intra-operative peritoneal lavage seems  to be more a 
historical based custom lacking any evidence based support [35].
Drainage or not   There seems to be no unanimity of opinion on this topic [16, 30]. In 
a questionnaire 80% of the responders answered that they would not leave a drain 
[30]. A drain will not reduce the incidence of intraabdominal "uid collections or 
abscesses [30]. On the other hand the drain site can become infected (10%) and can 
cause intestinal obstruction [30, 36]. Often a drain is left as a sentinel. However, in case 
of suspected leakage a CT- scan will provide all the information needed, probably 
better than a non-productive drain. 
c. De!nitive surgery  Indications for elective surgery are still not de!ned [19].  The 
number of elective procedures performed for PUD have declined with more than 70% 
since the 80’s [19, 22]. The results of a questionnaire with 607 responders showed that 
only 0.3% of the surgeons routinely perform a vagotomy for duodenal ulcer 
complications and 54.5% mentioned they never include it [37].  Reasons for decline in 
de!nitive ulcer surgery are: lower recurrence rate of PUD and PPU because of good 
results of H.pylori eradication and elimination of NSAID use. Also patients nowadays 
operated for PPU are older with higher surgical risk which make them less suitable 
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candidates for de!nitive ulcer surgery. Finally many surgeons practising today have 
limited experience with de!nitive ulcer operations [22]. Patients in which de!nitive 
ulcer surgery should be considered are those with PPU who are found to be H.pylori 
negative, or those with recurrent ulcers despite triple therapy [12, 19, 26, 38, 39]. In 
these patients a parietal cell vagotomy is recommended if necessary combined with 
anterior linear gastrectomy [40]. This procedure can be safely and relatively easy 
performed laparoscopically [19, 22]. 
d. Laparoscopy  Since the 90’s laparoscopic closure of a perforated peptic ulcer has 
been described. Laparoscopic surgery o#ers several advantages. First of all a 
laparoscopic procedure serves as a minimal invasive diagnostic tool.[41].  Other 
bene!ts from laparoscopic repair are postoperative pain reduction and less 
consumption of analgesics and a reduction in hospital stay [42]. Also a reduction in 
wound infections, burst abdomen and incisional hernia due to shorter scars has been 
noted [16, 42]. Avoiding upper laparotomy might lower the incidence of postoperative 
ileus and chest infections [16, 42]. Drawbacks are a prolonged operating time, higher 
incidence of re-operations due to leakage at the repair site and a higher incidence of 
intra-abdominal collection secondary to inadequate lavage  [16, 42, 43]. If the presence 
of these "uid collections have any clinical relevance is unclear. The higher incidence of 
leakage might be caused by the di$culty of the laparoscopic suturing procedure. First 
of all this emphasises the need for a dedicated laparoscopically trained surgeon to 
perform this procedure [13]. Alternative techniques to simplify the suturing process 
have been thought of. [13, 42].   Some laparocopic surgeons use omentopexy alone 
[12, 41]. Suture less techniques have been tried, in which !brin glue alone or a gelatine 
sponge has been glued into the ulcer [12]. The downside of this technique is that is 
only can be used to close small perforations. To overcome this problem a biodegradable 
patch, that can be cut into any desirable size, has been tested in rats, with good results 
[44]. Finally, combined laparoscopic-endoscopic repair has been described as well 
[45]. 
Postoperative management Reviewing literature all patients receive nasogastric 
probing for at least 48 hrs [16]. This however seems to be more “common practice” 
than evidence based medicine [46]. A recently published Cochrane review concludes 
that routine nasogastric decompression does not accomplish any of its attended goals 
18
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and should only be applied in selected cases, which has been supported by other 
trials as well [46-48]. This also means that oral feeding can be started early, as in 
colorectal surgery and that waiting for three days, as often is done according to 
protocol, is unnecessary [48, 49].    As can be seen in table 2 wound infections represent 
the second most common complication after surgery for PPU. Also the incidence of 
sepsis is 2.5%. Preoperative intravenous administration of antibiotics has proven to 
lower the overall infection rate [50]. Although for most surgical procedures a single 
dose seems to be su$cient, in case of  H. pylori infection triple therapy is recommended 
consisting of a proton pump inhibitor combined with clarithromycin and amoxicillin 
for 14 days [16, 27, 49, 50]. Upper gastrointestinal endoscopy is suggested to be 
performed after eight weeks to asses healing of the ulcers and to evaluate H.pylori 
status [49].
Postoperative complications  The postoperative complication most common 
observed was pneumonia, followed by wound infection. An overview of all compli-
cations and their incidences, based on reviewing literature are listed in table 2 [13, 16, 
19, 20, 42, 43, 51-55].
Risk factors in"uencing outcome  Mortality after surgery for perforated peptic ulcer 
is between 6-10% [20]. There are four main factors which can increase this mortality 
rate even up to 100%.  These are age > 60 years, delayed treatment (>24hrs), shock at 
admission (systolic BP < 100 mmHg)  and concomitant diseases [19, 21]. Also gastric 
ulcers are associated with a two- to threefold increased mortality risk [19, 22]. Boey’s 
score, which is a score based on scoring  factors as shock on admission, confounding 
medical illness, and prolonged perforation, has been found to be a useful tool in 
predicting outcome (table 3) [16, 23, 39, 51].
Perforated peptic ulcer in the elderly  Mortality rate after surgery for PPU is three to 
!ve times higher in the elderly up to 50% [56]. This can be explained by the occurrence 
of concomitant medical diseases but also by di$culties making the right diagnosis 
resulting into delay > 24 hrs [56]. In case of a perforated gastric ulcer or recurrent PUD 
(hemi)gastrectomy with vagotomy might be indicated, but overall simple closure is a 
safe procedure and there seem to be no need for de!nitive surgery in this group of 
patients since ulcer recurrence is only 14% [12, 56, 57].
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Conclusion  Surgery for perforated peptic ulcer still is a subject of debate despite 
more than an era of published expertise. Reviewing di#erent policies regarding for 
instance the indication for conservative treatment, sense or no sense of drains, the 
need for omentoplasty or not, performing the procedure laparoscopically and the 
need for de!nitive ulcer surgery, might contribute to establishing consensus.
Complication  Incidence
Pneumonia  3.6-30%
Wound infection  10-17%
Urinary tract infection  1.4-15%
Suture leak  2-16%
Abscess formation  0-9%
Heart problems (myocardial infarction, heart failure) 5%
Ileus  2-4%
Fistula  0.5-4%
Wound dehiscence  2.5-6%
Biliary leak  4.9%
Bleeding  0.6%
Re-operation  2-9%
Sepsis  2.5%
Stroke  4%
Death  5-11%
Table 2.  Overview complications after surgery for ppu [13, 16, 19, 20, 42, 
43, 51-55]
 Morbidity rate Mortality rate
Boey 0 17.4% 1.5%
Boey 1 30.1% 14.4%
Boey 2 42.1% 32.1%
Boey 3  100%
Table 3:  Boey’s score related to morbidity and mortality
20
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Abstract
Background Perforated peptic ulcer (PPU), despite anti-ulcer medication and 
Helicobacter eradication, is still the most common indication for emergency gastric 
surgery associated with high morbidity and mortality. Outcome might be improved 
by performing this procedure laparoscopically, but there is no consensus on whether 
the bene!ts of laparoscopic closure of perforated peptic ulcer outweigh the 
disadvantages such as prolonged surgery time and greater expenses.   
Methods An electronic literature search was done by using PubMed and EMBASE 
databases. Relevant papers written between January 1989 and May 2009 were 
selected and scored according to E#ective Public Health Practice Project guidelines. 
Results Data were extracted from 56 papers, as summarized in tables 1-7. The overall 
conversion rate for laparoscopic correction of perforated peptic ulcer was 12.4%, with 
main reason for conversion being the diameter of perforation. Patients presenting 
with PPU were predominantly men (79%) with an average age of 48 years. One-third 
had a history of peptic ulcer disease, and one-!fth took nonsteroidal anti-in"ammatory 
drugs (NSAIDs). Only 7% presented with shock at admission.  There seems to be no 
consensus on the perfect setup for surgery and/ or operating technique. In the 
laparoscopic groups, operating time was signi!cant longer and incidence of recurrent 
leakage at the repair site was higher. Nonetheless there was signi!cant less 
postoperative pain, lower morbidity, less mortality, and a shorter hospital stay.
Conclusion There are good arguments that laparoscopic correction of PPU should be 
!rst treatment of choice. A Boey score of 3, age over 70 years, and symptoms persisting 
longer than 24 h are associated with higher morbidity and mortality and should be 
considered contraindications for laparoscopic intervention. 
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Introduction
Since the late 1980s, laparoscopy has become increasingly popular. In the beginning 
laparoscopy was mainly used for elective surgery since it was not clear what the 
in"uence was of the pneumoperitoneum on the acute abdomen with peritonitis. 
However the bene!ts of laparoscopy with regard to the acute abdomen as a diagnostic 
tool have been established since, and also its therapeutic possibilities seem to be 
advantageous [1-3]. The rapid development of laparoscopic surgery has further 
complicated the issue of the best approach for the management of perforated peptic 
ulcer (PPU) [4]. PPU is a condition in which laparoscopic repair is an attractive option. 
Not only is it possible to identify site and pathology of the perforation, but the 
procedure also allows closure of the perforation and peritoneal lavage, just like in 
open repair but without a large upper abdominal incision [5,6]. Nonetheless, not all 
patients are suitable for laparoscopic repair [5].
Despite many trials (mostly non randomized or retrospective) the routine treatment 
for perforated peptic ulcer still seems to be by upper laparotomy, representing the 
main motive for reviewing the literature and summarizing all (signi!cant) results.
Methods
An extensive electronic literature search was done by using PubMed and EMBASE 
databases. Keywords used for searching were “laparoscopic” “correction” “repair” and 
“peptic ulcer”. All papers in English or German language published between January 
1989 and May 2009 were included. Papers were scored according to E#ective Public 
Health Practice Project (EPHPP) guidelines as advised in Jackson’s guidelines for 
systematic reviews [7]. Using this rating system a paper was classi!ed as weak, 
moderate or strong.
 
Results
Fifty-six relevant articles were found by PubMed and EMBASE search. Of these, 36 
were prospective or retrospective trials, 5 were review articles, 3 articles described 
new techniques making laparoscopic correction of PPU more accessible and 12 were 
general, of which 1 was the European Association for Endoscopic Surgery (EAES) 
guideline. [1-6,8-57]. Study details are listed in Table 1. Based on patient details and 
selection criteria as reported in these papers a general overview could be made of the 
average symptoms of a patient presenting with acute abdominal pain suspected for 
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PPU and of the results of additional diagnostic tools such as X-ray and blood sample 
(Table 2). Three papers published results of randomized controlled trials (RCTs).
[29,46,57]. Since these were the only RCTs comparing laparoscopic repair with open 
repair for PPU, their results have been listed separately in Table 3. All three showed 
signi!cant reduction in postoperative pain in the laparoscopic group, and Siu et al. 
concluded that morbidity was signi!cant lower in the laparoscopic group [29]. Two of 
these RCTs concluded that operating time was signi!cant longer, though the other 
group showed a signi!cant shorter operating time. In 29 studies the surgical technique 
used for laparoscopic correction of PPU was mentioned in the ‘Material and Methods’ 
section. These details are summarized in Table 4. Table 5 gives an overview of the total 
amount of complications observed after surgery for PPU by either laparoscopic 
technique or open closure. It is noticeable that the incidence of scar problems after 
surgery for PPU was as high as 9.9%. Also, mortality after surgery for peptic ulcer 
disease, despite all technical and medical improvement was still 5.8%. The average 
conversion rate was 12.4% (Table 1). Reasons for conversion are listed in Table 6. The 
three most common reasons for conversion were size of perforation (often > 10mm), 
inadequate ulcer localization and di$culties placing reliable sutures due to friable 
edges. Table 7 compares results between laparoscopic and open repair with regard to 
most important parameters such as postoperative pain, bowel action, hospital stay, 
morbidity and mortality. Finally Table 8 gives an overview of the conclusions drawn by 
40 papers.   
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  Study Number  Conversion 
Study EPHPP design patients Procedure rate (%)
Vaidya 2009 Weak NRP 31 Lap 6.5
Ates 2008 Moderate NRP 17 Lap 17.6
Song 2008 Weak NRP 35 Lap 5.7
Bhogal 2008 Moderate NRP 19 Lap 0.0
   14 Open 
Ates 2007 Weak NRP 17 Lap 17.6
   18 Open 
Malkov 2004 Moderate NRP 42 Lap 0.0
   40 Open 
Siu 2004 Moderate NRP 172 Lap 21.5
Arnaud 2002 Weak NRP 30 Lap 16.6
Lee 2001 Weak NRP 155 Lap 28.5
   219 Open 
Khourseed 2000 Weak NRP 21 Lap 4.7
Kathkouda 1999 Weak NRP 30 Lap 17.0
   16 Open 
Bergamaschi 1999 Weak NRP 17 Lap 23.5
  N 62 Open 
Matsuda 1995 Weak NRP 11 Lap 21.4
   55 Open 
Lee 2004 Weak NRP 30 Lap 3.3
Druart Moderate NRP 100 Lap 8.0
Siu 2002 Strong PR 63 Lap 14.2
   58 Open 
Lau 1996 Moderate PR 52 Lap 23.0
   51 Open 
Bertle# 2009 Strong PR 52 Lap 7.7
   49 Open 
Palanivelu 2007 Weak R 120 Lap 0.0
Lunevicius 2005 Moderate R 60 Lap 23.3
   162 Open 
Lunevicius IV Weak R 60 Lap 23.3
Kirshtein 2005 Weak R 68 Lap 4.4
   66 Open 
Tsumura 2004 Weak R 58 Lap 12.0
   13 Open 
Seelig 2003 Weak R 24 Lap 12.5
   31 Open 
Al Aali 2002 Weak R 60 Lap 6.6
   38 Open 
Lee 2001 I Weak R 209 Lap 26.8
   227 Open 
Robertson Weak R 20 Lap 10.0
   16 Open 
So 1996 Weak R 15 Lap 6.6
   38 Open 
Johansson 1996 Weak R 10 Lap 0.0
   17 Open 
Total   2788  12.4
NRP = non randomized prospective, PR = prospective randomized, R = retrospective
EPHPP = E!ective Public Health Practice Project
Table 1.  Overview studies
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WBC = white blood cells
 Total  n=2784
Age (years) 48 n=2328
Male (%) 79 n=2678
History of ulcer (%) 29 n=1140
History of NSAID use (%) 20 n=1109
Smokers (%) 62 n=472
Alcohol use (%) 29 n=198
ASA I (%) 35 n=1120
ASA II (%) 37 n=1060
ASA III (%) 20 n=1060
ASA IV (%) 9 n=1030
Boey 0 59 n=513
Boey 1 23 n=513
Boey 2 16 n=513
Boey 3 2 n=513
Shock at admission (%) 7 n=1107
Duration of symptoms (hrs) 13.6 n=837
Free air on x-ray (%) 85 n=510
Symptoms > 24 hrs (%) 11 n=723
Size perforation (mm) 5.5 n=691
Manheim peritonitis index 15.1 n=220
WBC 12.3 n=147
Localization ulcer Duodenal (%) 67 n=1355
 Juxtapyloric (%) 23 n=1355
 Gastric (%) 17 n=1355
Table 2.  Demographics of patients with perforated peptic ulcer disease 
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VAS visual analog scale
Laparoscopic correction Siu 2002 Lau 1996 Bertle# 2009 Average
Operating time (min) 42 94 75 70.3
Nasogastric tube (days) 3.0 2.5 2.0 2.5
Normal diet (days)  4.0  4.0
Postoperative opiate use 0 injections 1.5 days 1 day 
Hospital stay (days)  5.5 6.5 6.0
Morbidity (%) 25 23 18 22.0
Normal daily activities (days) 10.4   10.4
Mortality (%) 1.6 2 3.8 2.5
Ileus (days)   0 0.0
Woundinfection (%)   0 0.0
Leakage (%)  2.1 3.8 3.0
VAS day 1 3.5 4.0 3.8 3.8
VAS day 3 1.6  2.1 1.9
Open correction Siu 2002 Lau 1996 Bertle# 2009 Average
Operating time (min) 52.3 54 50 52.1
Nasogastric tube (days) 3.0 2.5 3.0 2.8
Normal diet (days)  4.0  4.0
Postoperative opiate use 6 injections 3.5 days 1 day 
Hospital stay (days)  5 8 6.5
Morbidity (%) 50 22 36 36.0
Normal daily activities (days) 26.1   26.1
Mortality (%) 5.2 4.0 8.1 5.8
Ileus (days)   2.0 2.0
Woundinfection (%)   6.1 6.1
Leakage (%)  2.2 0 1.1
VAS day 1 6.4 5.0 5.2 5.5
VAS day 3 3.3  3.0 3.2
Table 3.  Results of prospective randomized trials 
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Closure of perforation 66% omental patch 24% mixed techniques 10% sutures only
Pneumoperitoneum 26% Hassan trocar 47% veress needle 26% mixed
Pneumoperitoneum 75% 12 mmHG 25% 11 or 14 mmHg 
Cameraposition 35% supraumbilical 35% umbilical 30% infraumbilical
Number of trocars used 60% 4 trocars 40% 3 trocars 
   16%  6% 
Position surgeon 44% between legs 33% left side patient between  right
   of left side side
Irrigation "uid 45% generous 55% between 2-6 liters 
Camera 80% 30 degrees 10% 40 degrees 10% 0 degrees
Nasogastric tubing 94% yes 6%  no 
Abdominal drains 79% yes 21% no 
Suture material 64% resorbable 38% non-resorbable  sutures 
Knotting technique 64% intracorporeal 14% extracorporeal 14% mix
Table 4.  Surgical technique (29 studies)
MODS multiple organ dysfunction syndrome
Scar problems 9.9 %
Mortality 5.8 %
Intra abdominal collection 5.7 %
Wound infection 4.9 %
Mods 4.7 %
Sepsis 4.6 %
Reoperation 4.5 %
Prolonged ileus 4.1 %
Suture leakage 3.8 %
Pneumonia 3.4 %
Respiratory complications 3.3 %
Ulcer recurrence 3.1 %
Intraabdominal abcsess 2.7 %
Heart failure 2.3 %
Hemorrhage 2.0 %
Incisional hernia 1.8 %
Atrial !brillation 1.7 %
Fistula 1.7 %
Pneumothorax 1.7 %
Urine retention 1.7 %
Urinary tract infection 1.6 %
Cerebral vascular accident 1.0 %
Wound dehiscence 0.8 %
Table 5. Overview of complications (17 studies n=1802)
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Perforation size 9.4 %
Inadequate ulcer localization 6.6 %
Friable edges 6.4 %
Adhesions 5.9 %
Perforation galbladder 5.0 %
Cardiavascular instability 4.4 %
Suspected tumor 4.2 %
Severe peritonitis 4.2 %
Posterior localization 3.9 %
De!nitive ulcer surgery 3.2 %
Technical di$culties 2.2 %
Pancreatic in!ltration 1.0 %
Table 6.  Conversion reasons (21 studies, n=2346):
VAS visual analog scale
n=1874 Laparoscopic n=843 Open n=1031
Operating time (min.) 70.8 59.3
Nasogastric tube (days) 23 3.0
Intra venous "uids (days) 2.8 3.1
Abdominal drains (days) 2.2 3.8
Urinary catheter (days) 2.3 3.7
Normal diet (days) 3.5 5.7
Prolonged ileus (days) 2.7 3.6
Hospital stay (days) 6.3 10.3
Woundinfection (%) 0.0 5.0
Suture leakage (%) 6.3 2.6
Mobilization (days) 1.9 3.3
Normal daily activity (days) 12.7 16.6
Morbidity (%) 14.3 26.9
Mortality (%) 3.6 7.2
VAS day 1 3.8 6.4
VAS day 3 1.9 3.3
Table 7.  Laparoscopic versus open repair:
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Discussion
In 2002, Lagoo et al. added the sixth decision for a surgeon to be made regarding PPU 
to the existing !ve therapeutic decisions proposed by Feliciano in 1992 [4]. The !rst 
decisions were about the need for surgical or conservative treatment, to use 
omentoplasty or not, the condition of the patient to undergo surgery, and which 
medication should be given. The sixth decision was: “Are we going to perform this 
procedure laparoscopically or open?” Is there really a sixth decision to be made, or are 
there enough proven bene!ts from laparoscopic correction that this should not be a 
question anymore?  Reviewing literature showed that much research has been done, 
although not many prospective randomized trials have been performed (n=3). Still, 
data extracted from these papers are interesting. 
Patient characteristics: Often it was mentioned that age of patients presenting with 
PPU is increasing, due to better medical antiulcer treatment and also because of more 
NSAID and aspirin usage in the elderly population [4,17,56]. The results in Table 2 show 
that the average age of patients with PPU was 48 years and that only 20% of these 
patients had used NSAIDs. One-third of patients had a history of peptic ulcer. Although 
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VAS visual analog scale
The procedure is safe 16x
Signi!cant less pain 19x
Signi!cant less mortality 1x
Signi!cant lower morbidity 4x
Signi!cant shorter operation time 2x
Signi!cant shorter hospital stay 5x
Signi!cant faster resuming normal diet 3x
Signi!cant less wound infection  2x
 
No di#erence between laparoscopic repair or open 2x
 
Signi!cant longer operating time 8x
Signi!cant more suture leakage 3x
Signi!cant more reoperations 1x
Table 8.  Conclusions of 40 studies with regards to laparoscopic repair PPU
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Helicobacter pylori is known to be present in about 80% of patients with PPU, this 
might indicate that there are more factors related to PPU for which the pathology is 
not yet clear [4].  Sixty-seven percent of perforations were located in the duodenum 
and only 17% were gastric ulcers (Table 2), according to !ndings in literature[58].  In 
85% there was free air visible on X-ray (Table 2), which supports the diagnosis, but free 
air could be caused by other perforations as well and, although the diagnosis of PPU is 
not di$cult to make, sometimes there is a good indication for diagnostic laparoscopic 
to exclude other pathology[2]. In 93-98%, de!nitive diagnosis could be made by 
performing diagnostic laparoscopy in the patient with an abdominal emergency, of 
which 86-100% could be treated laparoscopically during the same session.[1,2].  
Surgical technique: There seems to be no consensus on how to perform the surgical 
procedure, which probably means that the perfect setup has not yet been found. 
Forty-four percent of surgeons preferred to stand between the patient’s legs, while 
33% performed the procedure at the patient’s left side. Also, the number, position and 
size of trocars di#ered between surgeons. Placing and tying sutures was more 
demanding laparoscopically, and two techniques were used (Table 4). Theoretically 
there is a preference for intracorporeal knotting over extracorporeal suturing, because 
the latter is likely to cut through the friable edge of the perforation [12]. One of the 
disadvantages of laparoscopic correction of PPU often mentioned was the signi!cant 
longer operating time, which causes more costs and may be nonpreferable in a 
hemodynamic unstable patient [5,16,18,35,42,43,45,46]. Ates et al. presented results 
with simple suture repair of PPU without using pedicled omentoplasty [11]. This 
signi!cantly shortened operating time, but the questions remains of whether it is safe 
to abandon omentoplasty completely. Cellan-Jones emphasized the necessity for 
omentoplasty [59]. His advised technique, to prevent tearing out of sutures and 
prevent enlargement of the size of perforation by damaging the friable edges, is to 
place a plug of pedicled omentum into the “hole” and secure this with three tie-over 
sutures. His technique is often called the Graham patch, but Graham describes in his 
article the use of a free omental plug, a technique hardly any surgeon uses 
nowadays[60]. It might be less confusion to use the term pedicled omentoplasty.  The 
usefulness of pedicled omentoplasty has been emphasized by others, and Schein 
even stated: “!rst suturing the hole and then sticking omentum over the repair is 
wrong, if you cannot patch it, then you must resect”[59,61]. Avoiding omentoplasty 
might shorten operating time but might be the reason for a higher incidence of 
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leakage at the repaired ulcer side [5,24]. Another reason for the longer operating time 
during the laparoscopic procedure might be the irrigation procedure. Peritoneal 
lavage is one of  the key interventions in the management of PPU [4]. Lavage was 
performed with 2-6 L  warm saline, but even up to 10 L has been described (table 3) [4]. 
By using a 5-mm or even 10-mm suction device, this part of surgery took even up to 58 
min [30]. Whether generous irrigation is really necessary has not been proven yet. 
Patient selection: Not all patients are suitable for laparoscopic repair, and it is important 
to preselect patients who are good candidates for laparoscopic surgery [5]. Boey’s 
classi!cation appears to be a helpful tool in decision making [4,56]. The Boey score is a 
count of risk factors, which are: shock on admission, American Society of 
Anesthesiologists (ASA) grade III-V, and duration of symptoms [52]. The maximum 
score is 3, which indicates high surgical risk. Laparoscopic repair is reported only to be 
safe with Boey score 0 and 1 [16,42]. Since the incidence of patients with Boey score 2 
and 3 is low (according to table 2, only 2% of patients were admitted with Boey score 
3, 7% were in shock at admission, and 11% had prolonged symptoms for more than 
24 h) and Boey 2 and 3 is associated with high morbidity and mortality rate anyway, 
independent of type of surgery, it is di$cult to !nd signi!cant foundation for this 
statement. Other reported contra-indications are age > 70 years, and perforation 
larger than 10mm in diameter [16,17,32,33].  
Reasons for conversion: Overall conversion rate was 12.4%, with a range from 0-28.5% 
(table 1). The most common reason for conversion was the size of perforation, but by 
using an omental patch this might not necessarily have to be a reason anymore to 
convert. From literature it was already known that other common reasons for 
conversion include failure to locate the perforation [17].  Shock at admission was 
associated with a signi!cant higher conversion rate (50% versus 8%)[4]. Furthermore, 
time lapse between perforation and presentation negatively in"uenced conversion 
rate (33% versus 0%)[4]. 
Complications: The best parameters to compare two di#erent surgical techniques are 
morbidity and mortality. PPU is still associated with high morbidity and mortality, with 
main problems caused by wound infection, sepsis, leakage at the repair site, and 
pulmonary problems (Table 4) [56]. Comparing results shows a remarkable di#erence 
in morbidity (14.3% in the laparoscopic group versus 26.9% in the open group) and 
mortality (3.6% versus 6.4%) (Table 6). Many trials measured the amount of 
postoperative opiate usage, but since this was scored in di#erent ways (days used, 
C h a p t e r  3
39
C h a p t e r  3
number of injection, amount of opiates in mg) these data were not comparable. 
However, overall, many studies showed signi!cant reduction in pain, mortality, 
morbidity, wound infection, resuming normal diet and hospital stay (Table 6 and 7). 
Of course there are some negative results which can not be ignored (Table 7). Three 
papers reported a signi!cant higher incidence of suture leakage, associated in one 
with a higher incidence of reoperations, but leakage mainly occurred in the sutureless 
repair group or in the group in which (pedicled) omentoplasty was not routinely used 
[18,24,32]. 
Overall there seems to be signi!cant prove of the bene!ts of laparoscopic repair, but it 
is technical demanding surgery which needs a surgeon experienced with laparoscopy 
[4,17]  CO2 insu%ation of the peritoneal cavity in the presence of peritonitis has been 
shown in rat models to cause an increase in bacterial translocation [4]. This led to the 
assumption that laparoscopic surgery might be dangerous in patients with prolonged 
peritonitis. Vaidya et al. performed laparoscopic repair in patients with symptoms of 
PPU for more than 24 h and concluded that is was safe even in patients with prolonged 
peritonitis, which has been con!rmed by others [4,8,39,44] .
Alternative techniques: closing the perforation site using suture repair is challenging, 
which is why alternative methods have been described [5,15,21,24,25,31]. Examples 
are represented by the sutureless  repair of PPU, in which the perforation is closed by a 
gelatine sponge glued into the perforation or the perforation is closed by !brin glue. 
Song  et al. proposed  the simple “one-stitch” repair with omental patch [9]. The 
automatic stapler has been used for perforation site closure, use of running suture 
was suggested to avoid intracorporeal or extracorporeal knotting, and combined 
laparoscopic-endoscopic repair has been described as well [21].
De!nitive ulcer surgery: the need for de!nitive surgical management of peptic ulcer 
disease has markedly decreased, but  0-35% of patients admitted for PPU received 
de!nitive ulcer surgery [8,16,20,56]. De!nitive ulcer surgery can be performed safely 
with laparoscopic techniques [4,12,36].  Palanivelu et al. performed de!nitive surgery 
in 10% of the cases admitted for PPU. All procedures (posterior truncal vagotomy and 
anterior highly selective vagotomy) were performed laparoscopically without 
conversion or mortality [12]. 
Research: a few aspects regarding laparoscopic repair of PPU are still unclear, and 
further research on these topics would be interesting. One of the remaining questions 
is whether there is less formation of intra-abdominal adhesions after laparosopic 
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repair [4] . If this is the case, it would be another convincing reason to perform this 
procedure laparoscopically. Often mentioned as one of the major disadvantages of 
laparosopic surgery are the high costs, caused by the need for more surgical sta# and 
laparoscopic equipment. However no speci!ed calculation of per- and postoperative 
costs have been made so far, and also the costs saved by possible earlier return to 
work have to be taken into account. 
To conclude, the results of this review support the statement of the EAES already 
made in 2006  that, in case of suspected perforated peptic ulcer, laparoscopy should 
be advocated as diagnostic and therapeutic tool [14].
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Abstract 
Background Laparoscopic surgery has become popular during the last decade, mainly 
because it is associated with fewer postoperative complications than the conventional 
open approach. It remains unclear, however, if this bene!t is observed after 
laparoscopic correction of perforated peptic ulcer (PPU).  The goal of the present study 
was to evaluate whether laparoscopic closure of a PPU is as safe as conventional open 
correction.
 Methods The study was based on a randomized controlled trial in which nine medical 
centres from the Netherlands participated. A total of 109 patients with receive a PPU 
repair. After exclusion of 8 patients during the operation, outcomes were analyzed for 
laparotomy (n=49) and for the laparoscopic procedure (n=52). 
Results Operating time in the laparoscopic group was signi!cantly longer than in the 
open group (75 min versus 50 min). Di#erences regarding postoperative dosage of 
opiates and the visual analog scale (VAS) for pain scoring system were in favor of the 
laparoscopic procedure. The VAS score on postoperative day 1, 3 and 7 was signi!cant 
lower (p< 0.05) in the laparoscopic group. Complications were equally distributed. 
Hospital stay was also comparable: 6,5 days in the laparoscopic group versus 8,0 days 
in the open group (p = 0.235).
Conclusions Laparoscopic repair of PPU is a safe procedure compared with open 
repair. The results considering postoperative pain are favor the laparoscopic 
procedure. 
Introduction
The incidence of perforated peptic ulcer (PPU) has declined over the past several years 
because of the introduction of anti-ulcer medication and Helicobacter eradication 
therapy (1,2). Nevertheless the incidence and mortality of PPU is 5-10%. The mortality 
will increase up to 50% if the perforation exists for more than 24 hours (3,4). There are 
several options for treatment of PPU, but the preferred treatment is surgery by upper 
abdominal laparotomy (5,6).
Mouret et al. published the !rst results of laparoscopic repair in 1990 (7). He concluded 
that it was a good method, that probably reduced postoperative wound problems 
and adhesions. After the success of laparoscopic cholecystectomy and other 
laparoscopic procedures, it was thought that patients would have less pain and a 
shorter hospital stay after laparoscopic correction of PPU (8,9). Various studies have 
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shown that laparoscopic suturing of the perforation is feasible, but there is still no 
proof of real bene!ts of laparoscopic correction (3, 6,10,11,12). Therefore we performed 
a multicenter randomized trial comparing open correction of PPU with laparoscopic 
repair.
Methods
Participants: Patients with symptoms of the clinical diagnosis of PPU were included in 
nine medical centers in the Netherlands participating in the LAMA (LAparoscopische 
MAagperforatie) trial between March 1999 and July 2005. Eligible patients were 
informed of the two surgical approaches and were invited to participate in the study. 
Exclusion criteria were the inability to read the Dutch language patient information 
booklet, inability to complete informed consent, prior upper abdominal surgery and 
current pregnancy. The ethics committees of all participating institutions approved 
the trial.
Randomization: Surgeons contacted the study coordinator after the patients had 
provided informed consent and randomization took place by opening a sealed 
envelope. The envelope randomization was based on a computer-generated list 
provided by the trial statistician. 
Surgical procedure:  All patients received intravenous antibiotics prior to the operation 
and were allocated for Helicobacter pylori eradication therapy according to established 
guidelines (13). The open surgical procedure was performed through an upper 
abdominal midline incision. Closure of PPU was to be achieved by sutures alone or in 
combination with an omental patch.  After repair of the defect cultures were drawn 
from the peritoneal "uid, after which the peritoneal cavity was lavaged. During lavage 
it was permissible to insu%ate the stomach to test for leakage of the closed defect. No 
method was speci!ed for closing the abdomen.
Laparoscopic repair was performed with the patient and the team set up in the 
“French” position. Trocars were placed at the umbilicus (video scope) and on the left 
and right midclavicular line above the level of the umbilicus (instruments). If necessary 
a fourth trocar was placed in the subxiphoid space for lavage or retraction of the liver. 
Surgeons were free to use either 0° or 30° video scopes for the procedure. The rest of 
the procedure was identical to that described above for open repair. No method was 
speci!ed for closing the trocar incisions.
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Postoperative follow up: Postoperative pain was scored by means of a visual analogue 
scale (VAS) for pain on days 1,3,7 and 28 ranging from 0 (no pain) to 10 (severe pain). 
In addition, the days during which opiates were used by the patients were registered. 
All complications, minor and major, were monitored. The treating surgeons determined 
time of discharge on the basis of physical well-being, tolerance of a normal diet and 
ability to use the stairs. For this reason, this was an unblinded trial. Postoperative 
hospital stay without correction for time spent in hospital as a result of non-medical 
reasons (inadequate care at home) was calculated. Patients were invited to attend the 
outpatient clinic at 4 weeks, 6 months, and one year postoperatively. They were asked 
to complete forms related to pain and use of analgesics. 
Statistical analysis: Data analysis was carried out according to the intention-to-treat 
principle as established in the trial protocol. Data were collected in a database, and 
statistical analyses were performed with the Statistical Package for Social Sciences for 
Windows (SPSS 15.0, SPSS Inc., Chicago, I., USA). A researcher blinded to the nature of 
the procedures performed all data analyses. The primary outcome of the trial was 
duration of hospital stay. The power analysis was performed on basis of a reduction in 
hospital stay by 1.5 days (10 - 8.5 days from admission) in favor of the laparoscopically 
treated group using a β of 0.80 and an α of 0.05. This resulted in a trial size of 50 
patients per group. Pearson Chi-squared test was used to compare categorical 
variables and the Mann-Whitney U test was used to compare continuous variables as 
we could not assume normal distribution because of the relatively small numbers. In 
Tables 1-6 medians and interquartile ranges (IQR) are reported. All data were analyzed 
according to the intention-to-treat principle; i.e., patients remained in their assigned 
group even if during the procedure the surgeon judged the patient not to be suitable 
for the technique assigned or if conversion was required. Null hypotheses were tested 
two-sided and a P value of 0.05 or less was considered statistical signi!cant.
Results
Patients.  A total of 109 Patients were included in the trial based on a high suspicion 
of PPU (Figure 1). Eight patients were excluded during operation because no gastric 
perforation was detected or a defect in other parts of the digestive tract was 
uncovered. Data for these patients were not collected and the patients were excluded 
from further analysis. The remaining 101 patients made up the study population; their 
baseline parameters are given in Table 1. Fifty-two patients were randomized for 
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laparoscopic repair and 49 for open repair of the perforation. Forty patients were 
female. The mean age of the patients was 61 years. The BMI (body mass index) was 
equally distributed between the groups, with a median of 22.5. Patients in both groups 
had been su#ering from symptoms for a mean duration of 11 hours, and those in the 
laparoscopic group presented with a median Mannheim Peritonitis index (14) of 19.5, 
whereas those in the open group had a median Mannheim Peritonitis index of 16. 
Thirty patients reported the use of non-steroidal anti-in"ammatory drugs (NSAIDs; 17 
laparoscopic versus 13 open), and 10 patients used proton pump inhibitors (6 
laparoscopic versus 4 open). Patient history revealed gastric ulcer disease in19 
patients.
Figure 1. Patient !ow chart
116 patients identi!ed
7 not randomized (no data available due to transfer to other hospitals)
109 patients randomized
8 randomized but not analyzed (2x no perforation found, 
5x bowel perforation, 1x invagination ileum)
     
 49 in open repair group 52 in laparoscopic repair group
    4 conversions
  48 laparoscopic repairs
VAS score day 1, 3,7
4 weeks outpatient follow-up
6 & 12 months follow-up
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Intraoperative !ndings. The discovered ulcer perforations were found to have a mean 
diameter of 10 mm, which did not di#er between groups (Table 2). Location of the 
perforated ulcers was distributed equally between groups. Defects were located in 
the prepyloric region (n=41), the postpyloric region (n=34) and at the pylorus (n=20). 
The median volume of lavage "uid used was 1,000 ml (range 100 ml – 5,000 ml). The 
surgeon decided the amount of lavage used. There was no consensus on how much 
was necessary. Median blood loss did not di#er between groups. Skin-to- skin time 
di#ered by 25 minutes, favoring open repair of PPU (table 2).
 Laparoscopic repair Open repair 
 n = 52 N = 49 p
Male: female ratio 1.3:1 1.9:1 
Median age (years) + IQR*  66 (25.8) 59 (29.5) 0.185
Median BMI (kg/m2)* + IQR 23 (4) 22 (5) 0.118
Median duration of symptoms (hours) + IQR 11 (17) 11 (19) 0.948
Median blood pressure systolic (mmHg) + IQR 125 (38.5) 130 (36.5) 0.457
Median blood pressure diastolic (mmHg) + IQR 75 (25.5) 75 (24.5) 0.596
Median heart rate (beats/min) + IQR  88 (34.0) 92 (21) 0.403
Median body temperature (°C) + IQR  36.9 (0.92) 36.8 (1.5) 0.658
Mannheim Peritonitis Index + IQR 19.5 (8.25) 16 (14) 0.386
Median white cell count (x109/L) + IQR  12.1 (8.9) 12.1 (7.75) 0.467
Median ASA score* + IQR  1.0 (1.0) 1.5 (1.0) 0.902
Table 1.  Baseline parameters
*  IQR = interquartile range, di!erence between 25th percentile and 75th percentile
*  BMI: body mass index
*  ASA: American Society of Anesthesiologists association score
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Intraoperative complications. Conversion to open surgery was required in four 
patients (8%). Reasons for conversion included the inability to visualize the ulcer 
defect because of bleeding (n=1/52; 2%), inability to reach the defect because of 
perforation in the vicinity of the gastroduodenal ligament and because of a dorsal 
gastric ulcer (n=2/52, 4%) and inability to !nd the perforation (n=1/52, 2%). 
Postoperative complications. Complications were statistically equally distributed 
between the two groups (Table 4). There were 12 complications in 9 patients in the 
laparoscopic group and 24 complications in 15 patients in the open group. Mortality 
was 4% in the laparoscopic group and 8% in the open group. In the laparoscopic 
group death was caused by sepsis due to leakage at the repair site. In the open group 
3 patients died because of pulmonary problems (ARDS, pneumonia) and 1 patient 
died after complications following a cerebrovascular accident (CVA) combined with 
respiratory insu$ciency.
 Laparoscopic repair Open repair 
 n = 52 N = 49 p
Median size of perforation (mm) + IQR 10.0 (7.0) 7.0 ( 6.0) 0.379
Number of patients with defect   
     Pyloric 8 12 
     Postpyloric 20 14 
     Prepyloric 19 22 
Median volume of lavage (ml) + IQR 1000 (1500) 1000 (1425) 1.000
Median bloodloss (ml) + IQR 10.0 (40.0) 10.0 (50.0) 0.423
Skin to skin time (min) + IQR 75 (47.2) 50 (25.5) 0.000
Table 2.  Intraoperative "ndings
 Laparoscopic repair Open repair 
 n = 52 N = 49 p
Median hospital stay (days) + IQR 6.5 (9.3) 8.0 (7.3) 0.235
Median duration of nasogastric 
decompression (days) + IQR 2.0 (3.0) 3.0 (1.3) 0.334
Table 3.  Duration of hospital stay, nasogastric decompression 
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Discharge. Time to discharge was similar for the two groups, with a median di#erence 
of 1,5 days (Table 3). Nasogastric decompression could be stopped after 2-3 days in 
both groups (Table 3).
Pain. Visual analog pain scores were in favor of laparoscopic repair (Table 5; p<0.005). 
Although the median duration of opiate use in the two groups was 1.0, the mean 
duration in the open group was found to be 0.6 days longer than in the laparoscopic 
group (Table 6). 
VAS appearance of scar. The VAS score for appearance of the scar left by the respective 
procedures (subjectively recorded in the same way as pain) di#ered by 2.3 points, 
favoring the laparoscopic procedure (7.7 vs. 5.4; P =0.033)
 Laparoscopic repair Open repair 
 n = 52 N = 49 p
- pneumonia 2 1
- respiratory insu$ciency 1 3
- ARDS  1
- cardiac problems 2 2
- sepsis 3 1
- leakage at repair site 2
- abscess  3
- ileus  1
- fascial dehiscence  1
- wound infection  3
- urinary tract infection  2
- incisional hernia  1
- CVA  1
- death 2 4
Total complications 12 24
Total of patients with complications ≥1 9 (18%) 15 (36%) p= 0.061
Table 4.  Postoperative complications
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Discussion
The need for surgery for PPU has declined enormously in Europe and America with 
reported rates ranging from 50 to 80%, thanks to e#ective gastric acid-reducing 
medication (15).  For this reason, as well as because many surgeons prefer upper 
laparotomy, it took more time than expected to include 100 patients in our study. 
Reasons given by surgeons who prefer open repair were that it is a more familiar 
procedure and it can be completed faster than laparoscopy. It was also noted that 
patients often undergo operation at night, when the surgeon on call was not always 
laparoscopically trained. 
Other randomized trials have already shown the feasibility of laparoscopic repair of 
PPU (3,4,6,10). Only a few had more than 100 patients, and some emphasized results 
from subgroups of patients (8,11,12). We did not subdivide our patients and included 
patients with risk factors for developing sepsis or conversion (10). 
In eight of the original 109 patients (7%) it became evident during the operation that 
the patient had a diagnosis di#erent from PPU. In the patients who were randomized 
for laparoscopy this discovery revealed the bene!t of laparoscopy as a diagnostic 
procedure indicating either an upper or lower abdominoplasty or continuation of the 
laparoscopy (16). Conversion rate in the laparoscopy group was 8% (4/52). This is 
much lower than reported in literature, where conversion rates as high as 60% were 
found (3,4,6).  This maybe partly explained by the fact that only trained and 
experienced laparoscopic surgeons (those performing at least 50 laparoscopic 
 Median VAS Pain score Median VAS Pain score
 Laparoscopic repair Open repair p
day 1+IQR 3.8 (3.0) 5.15 (2.5) 0.001
day 3+IQR 2.1 (2.5) 3.0 (2.4) 0.035
day 7+IQR 1.0 (2.0) 1.85 (2.8) 0.036
day 28+IQR 0.3 (0.7) 0.0 (1.7) 0.748
Table 5.  Postoperative pain
 Opiate requirement Opiate requirement
 Laparoscopic repair Open repair P value
Median duration (days) + IQR 1.0 (1.25) 1.0 (1.0) 0.007
Mean duration (days) ± SD 1.0 ± 0.9 1.6 ± 0.9 0.007
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procedures a year) participated in this trial, con!rming the belief that this procedure 
should only be done by experienced surgeons (3,4,5). Operating time was signi!cant 
longer in the laparoscopy group (75 min versus 50 min), which is comparable to 
reports in the literature (3,10). A possible explanation for the longer operative time is 
that laparoscopic suturing is more demanding (9,17), especially if the edges of the 
perforation are in!ltrated and friable. Sutures easily tear out and it is more di$cult to 
take large bites and to tie knots properly. Use of a single-stitch method described by 
Siu et al. (18), !brin glue, or a patch might solve this problem (12,19). Another reason 
for the increase in operating time is the irrigation procedure. Irrigating through a 
5-mm or even a 10-mm trocar is time consuming, and suction of "uid decreases the 
volume of gas and reduces the pneumoperitoneum. There is no evidence that 
irrigation lowers the risk of sepsis (20), so it might only be necessary if there are food 
remnants in the abdomen;  perhaps there is no need for it at all (20). One of the 
suspected risks of laparoscopic surgery is that of inducing sepsis by increasing 
bacterial translocation while establishing a pneumoperitoneum (6). This danger could 
not be con!rmed in our trial. Furthermore data suggest that there is a decrease in 
septic abdominal complications when laparosopic surgery is used (8).
Evidence already exists that laparoscopic correction of PPU causes less postoperative 
pain (6,12,17,18). The meta-analysis published by Lau (6) showed that eight out of ten 
studies showed a signi!cant reduction in dosage of analgesics required in the 
laparoscopic group. Also, the three studies that had included VAS pain scores showed 
consistently lower pain scores, as was observed in our study as well. Whether this will 
lead to a better quality of life for patients, especially during the !rst weeks after 
surgery still needs to be analyzed. Although patients in our series who underwent 
laparoscopy had less postoperative pain, there was no di#erence in the length of 
hospital stay in our two groups. In fact, hospital stay overall in our patients was very 
long. This was most likely caused by the fact that many patients, especially the elderly, 
could not be discharged because of organizational reasons. Of the 101 patients, 41% 
were 70 years or older (24 in the laparoscopic group versus 17 in the open group). It 
appears that the age of PPU patients is increasing, and this will eventually represent a 
signi!cant problem in the future (2,3). One bene!t of the laparoscopic procedure not 
often mentioned in literature (6) is cosmetic outcome. Nowadays patients are aware 
of this bene!t, and sometimes this is the reason why they demand laparoscopic 
surgery.
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In conclusion, the results of the LAMA trial con!rm the results of other trials that 
laparoscopic correction of PPU is safe, feasible for the experienced laparoscopic 
surgeon and causes less postoperative pain. Operating time was longer in the 
laparoscopic group and there was no di#erence regarding hospital stay or 
postoperative complications.  
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Abstract
Background  Despite the fact that several studies have been performed on the 
treatment of perforated peptic ulcer (PPU), there are still no guidelines for this 
problem. The aim of this study was to identify the current practice on the treatment of 
perforated peptic ulcer (PPU) amongst laparoscopic surgeons in Europe.
Methods  Members of the European Association for Endoscopic Surgery (EAES) were 
surveyed on their opinion about PPU surgery practices. A 21-item questionnaire 
containing questions about the current incidence of PPU, diagnostic tools, treatment 
strategies and operative techniques was sent by e-mail to all members of the EAES.  
Results  A total of 2327 questionnaires were delivered with 596 returned. The average 
number of patients with clinical suspicion on PPU annually seen was 17 per year. 
Signi!cant di#erences were found between the number of patients treated and the 
setting of practice of the respondents (p<0.001). 75% of the respondents reported a 
constant or increased number of operative procedures for PPU. 64% of the respondents 
perform CT-scan, when PPU is suspected, against 36% that never performs CT-scan. 
81% percent of the respondents prefer to start laparoscopically and 71% percent of 
them also close the ulcer laparoscopically. The most preferred closure technique (70%) 
is to suture the perforation !rst and apply a pedicled omentoplasty on top of it. Only 
14% of the respondents perform a “tyre-test” after the repair is established. The 
majority of the respondents (85%) do not perform de!nitive anti-ulcer surgery during 
the same procedure for closing PPU. The setting of practice and experience years of 
the surgeon does signi!cantly in"uence the perception of the incidence of PPU and 
treatment strategies.
Conclusions  Laparoscopic closure of PPU has become the procedure of !rst choice 
for laparoscopic surgeons in case of patients suspected for PPU. In practice de!nite 
anti-ulcer sugery seems obsolete. 
Introduction  
Due to the established success of laparoscopic cholecystecomy in the 90s, a 
multicenter trial was started in 1999 comparing laparoscopic closure of perforated 
peptic ulcer (PPU) to closure by upper laparotomy.1 Despite the fact it was a 
muliticenter trial, it took six years to randomize 100 patients. One of the reasons for 
this was represented by the hesitation of some of the surgeons, especially during 
night-time, to perform this procedure laparoscopically. Longer operating time, the 
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more time consuming laparoscopic irrigation procedure, more technically demanding 
suturing, with risk of tearing out of the sutures whilst tying or even enlarging the 
perforation, were responsible for this unpopularity. Also in literature the bene!ts of 
laparoscopic surgery for PPU were not as evident as for laparoscopic cholecystectomy 
or appendectomy. 2, 3, 4  A questionnaire was designed to evaluate the current practice 
with regard to PPU amongst laparoscopic surgeons in Europe. 
Methods  
In March 2010 a questionnaire was sent to all members of the European association of 
Endoscopic Surgery (EAES). After four weeks a reminder was sent. The questionnaire 
consisted of 21 questions. The !rst question was about the incidence of PPU in the 
hospital the surgeon worked, the second question was about the used diagnostic 
tool. Question 3 and 4 were about conservative treatment. Questions 5-11 were about 
surgical technique. Twelve and 13 were about postoperative policy. Information about 
de!nitive ulcer surgery was asked in 14 and 15 and the !nal 6 questions were on the 
surgeon pro!le.  
Results 
Response  The questionnaire has been sent to 2629 members of the EAES (European 
Association for Endoscopic Surgery). E-mail delivery failed in 302 cases due to 
unavailability of the mailboxes. Between March and May 2010, a total number of 596 
surgeons responded to the questionnaire. Of these, 56 were incomplete and were 
excluded from further analysis. This resulted in 540 complete questionnaires that were 
included in this study.
Respondents In table 1 the baseline characteristics of the respondents are 
enumerated. The majority of the respondents are practicising in a non-university 
teaching hospital (46%), 38% in an academic center and 16% in a private clinic. Of the 
respondents, 22% had more than 20 years of experience as a consultant, 35% between 
10 and 20 years and 43% had less experience than 10 years. Most of the surgeons 
(66%) performed at least 100 laparoscopic procedures each year. 29% between 20 
and 100 laparoscopic procedures and only 5% less than 20.
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Incidence  All respondents perform open or laparoscopic closure of PPU in their 
centers. A mean number of 17 patients with clinical suspicion on PPU were treated in 
the overall group of respondents per year. A signi!cant di#erence was found between 
the number of patients treated in academic centers, teaching hospitals and private 
practices, 22, 17 and 10 respectively (p<0.001). 75% of the respondents reported a 
constant or even increased number of operative procedures for PPU against 25% that 
reported a decreased number of patients.
Preoperative workup  When PPU is suspected, 63% of respondents perform CT-scan 
with (47%) or without (53%) oral contrast. 37% of respondents never perform CT-scan 
(Figure 1). Of the respondents, 52% report that they occasionally manage PPU 
conservatively (Figure 2). In this respect 14% reported that they had a protocol for 
conservative treatment for PPU, 86% had no guidelines. Some of the reported 
indications to start conservative treatment were high operative risk due to 
comorbidities, longer existing complaints and increased age.
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 n (%)
Experience
<10 years 223 (42.5)
10 - 20 years 186 (35.4)
>20 years 116 (22.1)
Laparoscopic procedures
<20 procedures 24 (4.6)
20 - 100 procedures 152 (29.0)
>100 procedures 348 (66.4)
Setting of practice
Academic center 200 (38.1)
General teaching hospital 241 (45.9)
Private hospital 84 (16.0)
Table 1. Baseline characteristics of respondents
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start laparoscopically and close 
laparoscopically when a defect is found
start laparoscopically and convert 
when a defect is found
start directly with a laparotomy and 
close the defect
other
Figure 3.  Open or laparoscopic procedure
4%
19%
72%
5%
never
less than 25% 
more than 25%
Figure 2.  How often is a PPU treated conservatively 
in your center?
48%
5%
47%
no
occasionally, without oral contrast 
occasionally, with oral contrast
normally, without oral contrast
normally, with oral contrast
Figure 1.  Is a CT scan, when a PPU is suspected, the 
imaging modality of standard use in your center?
17%
37%
13%
18%
15%
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0 - 500 ml
500 - 1000 ml
1000 - 1500 ml
1500 - 2000 ml
2000 - 2500 ml
2500 - 5000 ml
> 5000 ml
Figure 6.  Irrigation !uid
7%
22%
17%
14%
yes
sometimes
never
Figure 5.  Tyre test
27% 14%
59%
I prefer to use the pedicled omentoplasty 
drawn into the perforation
,SUHIHUWRVXWXUHWKHSHUIRUDWLRQÀUVW
and after this apply a pedic
I usually use a  free omentum plug 
I approximate the perforation by sutures 
without using any omentoplasty
Figure 4.  Closure technique
19%
1%
10%
70%
14%
4%
22%
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Operative procedure  Perioperative antibiotic profylaxis was administered by 96% of 
responding surgeons. The antibiotics most frequently used were Augmentin (43%) 
and Kefzol (42%). 4% of respondents did not use prophylactic antibiotics at all. Most 
of surgeons (72%) prefer to start laparoscopically and close the defect laparoscopically 
once they have decided to treat PPU operatively. 19% of respondents prefer to start 
directly with a laparotomy and 9% start laparoscopically and convert when PPU is 
detected (Figure 3). The majority of surgeons (70%) prefer to suture the perforation 
!rst and apply a pedicled omentoplasty on top of it. 19% of surgeons prefer to use the 
pedicled omentoplasty, drawn into the defect, with sutures knotted on top of the 
omentoplasty. The defect is closed with sutures without omentoplasty by 10% of 
respondents and 1% uses a free omentum plug to close the defect. (Figure 4) After 
repair of the defect only 14% of the surgeons tests the repair site by using the “tire-
test” (insu%ating some air into the nasogastric tube and !lling the abdomen with 
saline to test for bubbles) (Figure 5).
A biopsy of the PPU is taken by 19%, whilst 81% report that they never take a biopsy 
of the perforated area. The vast majority of the respondents do not perform de!nitive 
anti-ulcer surgery during the same procedure for closing PPU. About 85% of surgeons 
treat less than 5% of their patients with de!nitive anti-ulcer surgery. During surgery, 
83% of respondents use between 1000-5000 ml of irrigation "uid to clean the 
abdomen and 71% reported that they routinely leave a (sentinel) drain (Figure 6).
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diet for 1 - 3 days
Patients can use a normal diet as 
soon as possible
Depending on nasogastric 
production normal diet will be 
resumed
Figure 7.  Postoperative oral intake
50%
36%
14%
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Postoperative management  Postoperatively, 50% of participants prefer to put their 
patients on a "uid diet for 1-3 days routinely. 15% of surgeons give their patients a 
normal diet as soon as possible, whilst 35% let it depend on nasogastric tube 
production (Figure 7). Routinely Helicobacter pylori eradication therapy is administered 
by 49% of respondents, 51% let it depend on the opinion of the internal medicine 
specialists. 
Setting of practice (Table 2)  The setting of surgical practice is signi!cantly correlated 
to the protocol whether a CT-scan should be performed and if oral contrast is 
administered routinely. Compared to academic hospitals, signi!cantly less patients 
get oral contrast "uid in private hospitals before they get a CT-scan (15% vs 28.6%, 
p=0.002). Signi!cantly less surgeons who practice in an academic hospital take 
biopsies of the perforated area for possible malignancy (17.5% vs 29.8%, p=0.03). The 
perception of the academic surgeons also di#ers from the surgeon working in a 
private hospital about the incidence of PPU in time. Academic surgeons report a 
signi!cantly higher increase in the incidence of PPU compared to surgeons working in 
private clinics (46.2% vs 28.6%, p=0.01).
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 Setting of Practice
 Academic General Private Total (%) p-value
Standard CT-scan 
No-n(%) 76 (38) 88 (36.5) 28 (33.3) 36.6 
Occasionally, no OC-n(%) 34 (17) 25 (10.4) 19 (22.6) 14.9 
Occasionally, with OC-n(%) 28 (14) 48 (19.9) 10 (11.9) 16.4 
Normally, no OC-n(%) 30 (15) 47 (19.5) 24 (28.6) 19.2 0.002
Normally, with OC-n(%) 32 (16) 33 (13.7) 3 (3.6) 13.0 
     
Biopsy 
Yes-n(%) 35 (17.5) 42 (17.4) 25 (29.8) 19.4 0.03
No-n(%) 165 (82.5) 199 (82.6) 59 (70.2) 80.6 
Increase incidence of PPU 
Decreaesed-n(%) 46 (23.1) 56 (23.3) 27 (32.1) 24.7 
Constant-n(%) 61 (30.7) 102 (42.5) 33 (39.3) 37.5 
Increased-n(%) 92 (46.2) 82 (34.2) 24 (28.6) 37.9 0.01
Table 2. Setting of practice and treatment of PPU
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Experience of the surgeon (Table 3)  The more experienced surgeons are, the less 
they use oral contrast "uid for CT-scan (10.3% vs 16.6%, p=0.04) and the less they 
decide to treat a suspected patient for PPU conservatively (37.2% vs 60.3%, p=0.001). 
In contrast to academic surgeons, experienced surgeons in other hospitals report a 
signi!cantly lower increase of the incidence of PPU compared to less experienced 
surgeons (31% vs 44.6%, p=0.04).
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 Experience as consultant
 <10 years 10-20 years >20 years Total (%) p-value
Standard CT-scan 
No-n(%) 78 (35) 73 (39.2) 41 (35.3) 36.6 
Occasionally, no OC-n(%) 32 (14.3) 27 (14.5) 19 (16.4) 14.9 
Occasionally, with OC-n(%) 46 (20.6) 26 (14.0) 14 (12.1) 16.4 
Normally, no OC-n(%) 30 (13.5) 41 (22.0) 30 (25.9) 19.2 
Normally, with OC-n(%) 37 (16.6) 19 (10.2) 12 (10.3) 13.0 0.04
Conservative treatment
Never-n(%) 83 (37.2) 99 (53.2) 70 (60.3) 48.0 0.001
Less than 25%-n(%) 129 (57.8) 80 (43.0) 41 (35.3) 47.6 
More than 25%-n(%) 11 (4.9) 7 (3.8) 5 (4.3) 4.4 
Increase incidence of PPU
Decreaesed-n(%) 44 (19.8) 55 (29.7) 30 (25.9) 24.7 
Constant-n(%) 79 (35.6) 67 (36.2) 50 (43.1) 37.5 
Increased-n(%) 99 (44.6) 63 (34.1) 36 (31) 37.9 0.04 
Table 3. Experience as consultant and PPU treatment
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Discussion
In literature, laparoscopic correction of PPU does not seem to be as popular as other 
laparoscopic procedures because of longer operating time, higher costs, the unclear 
e#ect of pneumoperitoneum on peritonitis and hemodynamics, especially in a septic 
patient. 5-8  It is also often mentioned that the incidence and the need for surgery for 
PPU has declined, both suggesting that laparoscopic correction of PPU is seldomly 
performed . 9, 10  The outcome of this questionnaire gives, with a response rate of 26%, 
a good impression about the situation in Europe at this moment. The surgeons are 
equally divided between academic hospitals and other hospitals and 57 % of surgeons 
has been working for more than 10 years. Annually they see a mean of 17 (range 
0-100) patients a year suspected for PPU.  The overall impression, in contrast to 
literature, is that during the last !ve years the incidence of PPU has been constant or 
even increased. 9, 10 Almost 70% of the responding surgeons perform more than a 100 
laparoscopic procedures a year, and since all of them are members of the EAES, this 
group is not representative for all gastrointestinal surgeons. Despite this, more than 
half of responding surgeons do not think it to be necessary for PPU to be operated by 
surgeons specialized in gastrointestinal surgery.
To con!rm the diagnosis of PPU, only in 31.3%, a CT scan is used as a routine. On 
whether this should be with or without the use of oral contrast, opinions are equally 
divided. Almost 40% does not see any need for using CT scan at all. The majority of 
surgeons (71.7%) will start with laparoscopic inspection if there is clinical suspicion of 
PPU and an X-ray with subdiaphragmatic free air. Especially high-volume laparoscopic 
surgeons choose more frequently for primarily laparoscopic approach.  Still though, 
one out of !ve laparoscopic surgeons start with an upper laparotomy. 
In literature some information can be found on safety of conservative treatment, 
especially about which patients would be good candidates for it. 11, 12 In this respect, 
more than half of surgeons (51.7%) does treat patients conservatively once in a while. 
Apparently conservative treatment still has its indications, but a guideline about 
patient selection or method of conservative treatment is lacking. Surgeons with more 
than 20 experience years chose signi!cantly less for primarily conservative treatment. 
This could possibly be related to negative experiences during their longer career.
In 1937 Graham described the use of a free omental patch for closing PPU. Although 
in textbooks the Graham patch is often advised as preferred technique for closing 
PPU, hardly anyone uses this technique nowadays (1.4%).  Also the Cellan-Jones patch 
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(suturing omentum on top of PPU without closing) is hardly ever used. Surgeons 
apparently prefer to close PPU !rst and suture a pedicled plug of omentum on top of 
it (omentoplasty). The overwhelming popularity of the latter technique implies a risk 
that the Cellon-Jones technique without the possibility of tearing out sutures at the 
edge of PPU might be forgotten as a safe alternative especially in case of large PPU. 13
Hard evidence for the necessity of irrigating the abdomen is lacking. 14 More than 80% 
of surgeons prefer to irrigate the abdomen with at least 1L. 
There seems to be consensus about the avoidance of taking a biopsy in case of PPU, 
because the risk of gastric cancer is low.15, 16 Also the usefulness of prophylactic 
administration of antibiotics is largely accepted. No consensus on the speci!c type of 
antibiotics however exists.17
The tire test and the dye test (dye via nasogastric tube) to exclude persistent leakage 
after closure of PPU are seldomly used. Only 14.1% of surgeons use one of the above-
mentioned methods as a standard routine. Both tests are easy to perform, do not take 
much time and might lower the risk of recurrent leakage.
The results of a questionnaire performed by Schein showed that 80% of the questioned 
surgeons did not leave a drain after surgery for acute abdomen. Reasons for this are 
that a drain will not reduce the risk for intraabdominal "uid or abscess formation, and 
that an intraabdominal drain is associated with higher morbidity because of infection 
or bowel obstruction.  The results from our questionnaire however shows the opposite, 
still 71.4% of surgeons prefer to place an intraabdominal drain. 18
Only 14.6% of patients is given a normal diet postoperatively as soon as possible. 
Nasogastric production still is a leading factor in decision making when to restart 
normal diet. Helicobacter eradication therapy is routinely given by 48.9% of surgeons. 
The other half of surgeons will consult an internal medicine specialist !rst. According 
to the guidelines, it is recommended that PPU patients positive for Helicobacter pylori 
should be treated with antimicrobial agents, which implicates that testing for 
Helicobacter per- or postoperatively is necessary. 19, 20
The need for performing de!nitive anti-ulcer surgery, during the same procedure for 
closing PPU, is estimated low by the interrogated surgeons. 
For conclusion laparoscopic closure of PPU has become the procedure of !rst choice 
for laparoscopic surgeons in Europe for PPU, In contrast to literature the incidence of 
operations for PPU seems not to have been further declined during the last years.
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Abstract 
Background  The aim of this study was to develop a simple method for closure of a 
perforated peptic ulcer, making it more accessible for laparoscopic surgery. 
Methods  An experimental pilot study was performed using !ve male Wistar rats. The 
perforation was closed by a bioabsorbable patch made of lactide–glycolid– 
caprolactone !xed with glue onto the outside of the stomach. 
Results Postoperatively, there were no signs of leakage or other complications. 
Histologically, there were no signs of in"ammation on the inside of the stomach, and 
there was a 50% reduction of the perforation each successive postoperative week. No 
adverse reactions because of the degradable material or glue were observed. 
Conclusions Treatment of a perforated peptic ulcer by placing a patch of biode-
gradable material like a ‘‘stamp’’ on the outside of the stomach is a feasible option. 
Introduction  
Laparoscopic correction still is not the gold standard for management of a perforated 
peptic ulcer 1 although many advantages of laparoscopic procedures have been 
demonstrated during the recent years with regard to postoperative morbidity and 
pain 2-4. During a multicenter Dutch trial (LAMA trial), we compared laparoscopic 
closure of perforated peptic ulcer with the conventional method using laparotomy. It 
seemed that one of the problems with the laparoscopic procedure involves the 
suturing technique 5. It is especially di$cult for surgeons to take big bites, to prevent 
cutting out of the sutures 4, and to exert su$cient tension on the knot during intra-or 
extracorporal knotting. The operation time for laparoscopic correction often is 
prolonged 5, 6, which is mainly due to the learning curve with regard to suturing 
technique. This may be the reason why many surgeons (especially during the night) 
are not even starting up laparoscopically or soon convert to laparotomy. A new 
method has been developed in which perforation of the stomach in rats was closed 
with a biodegradable patch !xed with glue, similar to putting a ‘‘stamp’’ on the outside 
of the stomach. In the current experiment, this ‘‘stamp’’ method was evaluated. 
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Methods  
Five adult male Wistar rats with an average weight of 255 grams were used in this trial. 
With the rats under general anesthesia (iso"urangas 2% with oxygen), a median 
laparotomy was performed. At a !xed point on the ventral side of the stomach, a 
perforation was created with a diameter of 0.5 cm. A patch, made of lactide–glycolid–
caprolactone (LGC) (Polyganics, B.V., Groningen, The Netherlands) was cut into a circle 
with a diameter of 1 cm and an overlap of 0.5 cm all around the perforation. The patch 
was glued on the outside of the stomach with Glubran 2 (n-butyl [2] cyanoacrylate, 
methacryloxysulfolane). The abdomen was closed in two layers with Polysorb 4-0. 
After 1week, the !rst rat underwent relaparotomy under general anesthesia. After 
inspection of the abdomen, the patch, including the full thickness of the stomach 
wall, was resected and sent for histology. Each successive postoperative week, one rat 
underwent the same procedure, resulting in a total clinical and histologic follow-up 
period of 5 weeks. For histology, tissue specimens were rinsed in saline and placed 
into a !xative containing 2% glutardialdehyde bu#ered with 0.1 mol/ phosphate 
bu#er, pH 7.4. Then, the specimens were dehydrated through a graded concentration 
of ethanol and embedded in glycol methacrylate. From all samples, 2-lm-thick sections 
were prepared using a disposable histoknife and a Reichert–Jung ‘‘2050 supercut’’ 
microtome. The sections were mounted on glass slides and stained with toluidine 
blue and alkaline fuchsin (Merck, Darmstadt, Germany). All the sections were evaluated 
and photomicrographed using a Olympus BX-50 microscope (Olympus Optical Co., 
Japan) 
Results  
All the rats survived the !rst operation without complications. The mean operating 
time was 10 min. At relaparotomy, there were neither signs of leakage nor evidence of 
peritonitis. There were small adhesions, mainly to the liver, and in the !rst two rats 
there also were small adhesions between the spleen and the stomach. From week 1, 
the patch was covered by omentum. Biodegradation of the patch was visible at week 
5. The diameter of the perforation, as observed from the inside of the stomach, 
decreased by 50% every week. After 5 weeks, only a pinpoint perforation could be 
found. All the rats gained weight during their weeks of follow-up evaluation, with an 
average weight of 348 g (range, 313– 392 g), on the day of re-operation meaning they 
were in good condition. 
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Histology  
At 1 week postoperatively, no in"ammatory cells were detected on the inside of the 
stomach. Bacteria were found in the super!cial mucous layer of the epithelium, and 
among the microvilli of epithelial cells. They were distributed irregularly, patchy and 
with heavy colonization, in some areas but did not invade the epithelium. The mucosa 
consisted of dense connective tissue and numerous blood vessels. The basement 
membrane underlying the epithelial basal cells was clearly visible. The muscular layer 
and submucosal glands were present, but did not continue, as was to be expected. At 
2 weeks postoperatively, cellular ingrowth of in"ammatory cells, especially 
granulocytes, was seen lying against the LGC patches. Multinucleated giant cells also 
were seen at the interface of the patches. At 3 weeks postoperatively, the LGC patches 
were covered by a capsule of !brotic tissue. This capsule consisted of 14 to 15 layers of 
!broblasts, collagen !bers, extracellular matrix, and numerous blood vessels. Still, 
some multinucleated giant cells were observed in the patches, and degradation of the 
LGC patches had begun. At 4 weeks postoperatively, the amount of in"ammatory 
in!ltrate had increased, while other cells such as macrophages and multinucleated 
giant cells were seen in!ltrating the LGC-patches. The capsule of !brotic layer became 
ticker. Fibroblasts as well as collagen !bers and blood vessels were found more 
frequently and denser, as compared with !ndings 3weeks postoperatively. 
At 5 weeks postoperatively, the !brotic layer on the patch had increased Macrophages 
and giant cells still were found in!ltrating and phagocytosing the LGC patches. There 
were epithelial cells close to the perforation. The muscular layer still showed 
perforation. There were no signs of rejection (Figs. 1 and 2). 
Fig. 1. Histology at week 1
Perforation
Inside stomach
75
C h a p t e r  6
Discussion  
A new method for closure of peptic ulcer perforation was tested in rats, and the !rst 
results seem promising. Sealing of the perforation with a glued biodegradable patch 
seemed su$cient because no leakage occurred. Furthermore, no in"ammation or 
other side e#ects to the abdominal wall were observed. It was decided that at this 
phase, the use of an iatrogenically made perforation would be su$cient, because we 
wanted only to evaluate whether this new technique would work. Of course, this test 
did not completely mimic the clinical situation. There was no edema, no !brin 
deposition, and no in"ammation of surrounding tissue. However, no clinical evidence 
so far had proved that a perforation of any longer duration with !brin deposition has 
a worse outcome with regard to healing of the perforation itself and a higher risk for 
reperforation. It could even be suggested that !brin deposition helps in sealing the 
perforation, but more research on this topic is needed. Closure of a perforated peptic 
ulcer by a Graham omental patch or mere sutures has been performed for many 
years 3, 7. Several alternative techniques have been tried 4, 7. The incentive for introducing 
these new operations was to simplify the procedure and make it suitable for minimal 
invasive therapy 4. A few procedures can be accomplished by endoscopy, but often it 
still is necessary to combine it with laparotomy or laparoscopy 6, 8. Lau et al. described 
a method for closing the perforation using spongostan !xed with !brin glue 9. This 
seemed to be suitable only for smaller perforations. The patch used in this study can 
be introduced through a trocar and unfolded with ease because it has no memory. 
Glubran 2, the glue used in this trial, is a synthetic surgical glue european conformity 
(CE) certi!ed for internal use. It is liquid, does not need any preparation and can be 
Fig. 2. Histology at week 5
Closed
Perforation
Muscle layer
Fibrotic layerPatch
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applied to the patch inside the abdomen using a laparoscopic needle. The size of 
the perforation does not matter because the patches can be cut easily into any 
desired size. 
In conclusion we propose a simple technique for closure of a perforated peptic ulcer, 
making laparoscopic correction of a perforated peptic ulcer more accessible. A 
randomized clinical trial will be initiated in due course. 
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Abstract
Background The current treatment of perforated peptic ulcer is primary closure, 
supported by the application of an omental patch. It is di$cult and time-consuming 
to perform this procedure by laparoscopic surgery, largely because of the required 
suturing. It was our aim to develop and test a new method of closure for gastric 
perforation that is similar in e$cacy and safety to a traditional repair. This technique 
could have utility in laparoscopic repair, as it does not require sutures or mobilization 
of the omentum. 
Method   The new method, called “stamp” method consists of closure of the perforation 
by gluing a biodegradable patch made of lactide-glycolide-caprolacton (LGC, 
Polyganics, B.V. Groningen, The Netherlands) on the outside of the stomach. It was 
compared with the omental patch procedure. Perforations were made in the stomach 
of 20 rats and closed by either method (10 rats in each group). The rats were followed 
for 10 weeks.
Results  No complications were seen in any of the rats. In both groups, histological 
degradation of the patch by giant cells started at week 2. There were no signs of 
in"ammation in either group. Signs of closure of the mucosa were seen after 2 weeks, 
and the muscular layer started to regenerate after 8 weeks in both groups. 
Conclusion  Results of both methods were similar, which means that treatment of a 
gastric perforation through the application a biodegradable patch to the outside of 
the stomach is a feasible option and might be even be an interesting technique for 
closure of other perforations in the digestive tract.  
Introduction
The current treatment of perforated peptic ulcer is primary closure, covered by 
omentoplasty. The classical Graham patch technique, described by Cellan-Jones in 
1929 and in 1937 by Graham can be applied 1-3. The idea in closing the perforation not 
only by sutures but also with an omental plug is the sealing and tamponade e#ect of 
the plug.  Adding an omental plug also reduces the risk of tearing out sutures, 
accelerates ulcer healing, and inhibits ulcer recurrence 4, 5. Laparoscopic surgery has 
gained in popularity, because there seems to be a decrease of postoperative 
complications, pain, and length of hospital stay 6-9. Despite this, laparoscopic correction 
of a perforated peptic ulcer (PPU) still is not the !rst treatment of choice for many 
surgeons.  One of the disadvantages of laparoscopic closure of perforated peptic ulcer 
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is that it takes more operating time and requires more operating skills, which makes 
the procedure more costly and less popular 9, 10. The prolonged operating time might 
be caused by the laparoscopic suturing procedure 6, 10. There is a learning curve for 
laparoscopic intracorporeal or extracorporeal suture techniques, and because of the 
fragile edges of the peptic ulcer walls, sutures tear out easily 10. An alternative 
technique for closing the perforation, avoiding the necessity to use stitches, might 
facilitate the laparoscopic procedure. An alternative to omentoplasty and stitching 
could be the use of a glued patch of biodegradable material on the outside of the 
stomach. Besides reducing operating time, another advantage of using a glued patch 
instead of suturing is that touching of the friable edges is avoided, which lowers the 
risk of enlarging the perforation. Also the patch method might be the solution for 
closing larger peptic ulcers. Performing an omentoplasty in these patients is di$cult, 
and alternative techniques have been tried 7, 11-13. Previously the “stamp method,” 
closing a gastric perforation with a biodegradable stamp, was tested in a pilot study in 
5 rats, showing that is was a safe procedure 14. In this pilot study there was no control 
group and the follow up period was only 5 weeks. Therefore, a new rat study has been 
performed in which we compare closing an iatrogenic perforation in rats’ stomachs by 
Graham omentoplasty with the application of a glued biodegradable (lactide-
glycolide-caprolacton) patch to the outside of the stomach. The aim of this study was 
to test the stamp method, which has to be a technique of a similar safety pro!le as 
primary closure and omentopexy but could allow the laparoscopic procedure to be 
done more easily so operating time can be reduced.
Methods
Twenty male Wistar rats, 12 weeks to 13 weeks old (Harlan, The Netherlands) were 
used in this trial, which was approved by the animal ethical committee of the 
University Medical Center Groningen. Ten rats were in the omentum group, and 10 in 
the stamp group. All procedures were performed with the rats under general 
anaesthesia by using iso"urane gas at 2% with oxygen. In both groups, an upper 
laparotomy was performed, and a perforation was created on a !xed point on the 
ventral side of the stomach. Because this was located underneath the liver lobe, 
careful retraction of the liver lobe was necessary. The perforation was made by cutting 
a small hole, with a diameter of 0.5 cm in the gastric wall. In the omentum group, the 
perforation was closed by using a Graham patch. For this, the omentum nearby the 
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perforation side was mobilized and !xed, pedicled, into the perforation with mattress 
stitches. A 6-0 Vicryl suture was used (Figure 1). In the stamp group, a circular shaped 
patch made of lactide-glycolide-caprolacton (LGC, Polyganics, B.V. Groningen, The 
Netherlands) with a diameter of 1 cm was glued on top of the perforation (Figure 2), 
ensuring an overlap of 0.25 cm around the perforation. 
The glue used was Glubran 2 made of NBCA (n- butyl 2 cyanoacrylate) OCA (2- octil 
cyanoacrilate), which has been approved for intracorporeal usage (GEM, Italy). Only a 
few drops needed to be applied on the dry biodegradable patch, which then was 
glued onto the gastric wall surrounding the perforation. After repair of the perforation 
by either one of the above techniques, the abdomen was irrigated with saline 0.9% 
and closed in 2 layers with Polysorb 4.0. Directly postoperatively, one subcutaneous 
dosage of 0.1 ml Temgesic (0.3 mg/ml) was given as analgesic. Rats were fed standard 
rat chow and received nonacidi!ed tap water. After one week, one rat, from either 
group was brought under general anesthesia again and underwent relaparotomy. 
After inspection of the abdomen, the rats were !rst perfused transcardially with 
“prerinse” containing 0.9% NaCl and 1% heparin, followed by 200 mL 2% glutaraldehyde 
bu#ered with 0.1 mol/L phosphate bu#er, pH 7.4. A full-thickness biopsy with a 
diameter of 2 cm was then taken from the perforation site and post!xed for several 
days in the same !xative. The specimens were then dehydrated through a graded 
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Figure 1:   Drawing of Graham omentoplasty. 
A suture runs through the gastric wall "rst; 
than takes a bit bite of pedicled omentum en 
runs back to the other site of the perforation.
Figure 2:  The stamp method: the 
biodegradable patch is glued on the outside 
of the stomach with 0.25 cm overlap.
Pedicled Omentoplasty
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concentration of ethanol and embedded in glycol methacrylate. From all specimens, 
2-µm thick slices were prepared using a disposable histoknife and a Reichert-Jung 
“2050 supercut” microtome. The sections were mounted on glass slides and stained 
with toluidine blue. In addition, some sections were evaluated and photomicrographed 
using an Olympus BX-50 microscope (Olympus optical Co, Japan). Every following 
week one rat from each group underwent the above mentioned procedure. 
Results
All 20 rats survived the operations without complications; none of the rats died or 
showed any signs of peritonitis, sepsis, or wound infection. The most important clinical 
sign of peritonitis due to leakage, caused by insu$cient sealing of the perforation, is 
that the rats do not eat and will not gain or even loose weight. The weight on the day 
of the !rst surgery (creating the perforation and closure by stamp method or omentum 
patch) was measured. On the day of relaparotomy, the weight was measured again. 
All rats, except one in both groups gained weight. The rat in the stamp group that did 
not gain any weight and the one in the omentum group that lost some weight were 
rats that already had their second surgery after one and two weeks so had less time to 
recover from their !rst surgery. 
During relaparotomy in both groups, no signs of leakage or peritonitis were found. 
Some adhesions of the liver to the stomach were found, mainly in the omentum 
group, but no o$cial scoring system for classifying the number or severity of adhesions 
was used. If adhesions were present, adhesiolysis needed to be performed to get a 
proper accessibility to the perforation site. This caused slightly more bleeding.
Histology
In the !rst week in both groups, a sign of in!ltration of the area by granulocytes was 
observed. At the start of week 2, invasion of the biodegradable patch by giant cells 
was observed, indicating that degradation of the patch was started. Also in both 
groups, closure of the epithelioid layer of the mucosa was seen.  In week 3, a !brotic 
layer started to form on the outside of the biodegradable patch (Figure 3).
In the following weeks, this developed into a well-organized, vascularized and 
structured layer. This phenomenon was not seen in the rats in which the omental 
patch was used (Figure 4). In this group, the fat cells of the omentum were covering 
the perforation site. In week 6, newly formed muscle cells crossing the perforation site 
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were found (Figure 5). In the following weeks, the perforation site was slowly 
narrowing.  The collagen was getting organized, and giant cells (Figure 6) were !lled 
with patch material. These giants cells were only found in the group with the 
biodegradable patch. The muscle layer seemed to be repaired and continuous after 8 
weeks (Figure 7), comparable in both groups. In both groups granulocytes were found 
during the complete period, slightly more in the patch group, but in none of the 
groups were there any signs of in"ammation or rejection. In the ninth week, the 
amount of giant cells started to decrease.  At week 10, the patch was almost completely 
absorbed. 
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Figure 3:  Week 6. Biodegradable patch (*1), covering defect. Patch is covered 
with a well-organized "brotic layer (*2). Giant cells invading patch (     ).
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Figure 4:  Week 8. Omentum covering the perforation side (*1). 
The perforation can still be seen in the noncontinuity of the muscle (*2).
Figure 5:  Perforation site at week 6 covered with omentum. 
New muscle cells start "lling up the perforation.
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Figure 6:  Three giant cells invading “stamp”. 
Giant cells are "lled with small particles of patch material. 
Figure 7:  Young muscle "bers closing old perforation side. 
White line is remaining op biodegradable patch at week 8.
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Discussion
This new method for closure of a perforated peptic ulcer has previously been tested in 
a pilot study of 5 rats10.  In the literature, we found no information on the histological 
phases of recovery of the stomach after perforation, and because of this, there was no 
guideline in what the follow-up period should have been to observe full healing. In 
the pilot study, there was only a follow-up of !ve weeks, and the muscle layer still 
showed signs of perforation after this period. To get more information on the healing 
process of the gastric wall, a longer follow-up period was necessary. Therefore in the 
new study, 10 rats were allocated to each group; one rat from each group was 
terminated weekly, which provided an overview of the healing process of 10 weeks. 
The histology results from this study have shown that after 1 week in both groups the 
epithelioid layer of the gastric mucosa already has been repaired. The muscular layer 
takes longer. After 6 weeks, in-growth of muscle !bres is seen, but the perforation site 
is still recognizable. After 8 weeks, the muscle layer in both groups was continuous.
There were no signs clinical or histological of in"ammation or rejection in either 
groups. De biodegradable patch is absorbed by giant cells, and this process already 
starts after 1 week. But the giants cells !lled with patch material were disappearing 
after 10 weeks.  One of the great advantages of using a stamp to cover the perforation 
is that the size of the perforation does not seem to matter, because the patch can be 
cut into any desirable size. Using glue instead of stitches simpli!es and speeds up the 
procedure. The use of a degradable patch replaces the need for omentoplasty. 
Apparently the necessity for the omental plug considering its sealing and tamponade 
e#ect is arguable 4, 5. Ates et al have already suggested simple laparoscopic repair 
without an omental patch 15. Avoiding an omentoplasty might lower the formation of 
intraperitoneal adhesion, but unfortunately, this was not o$cially scored and needs 
further research. Because it is not necessary to mobilize the well-perfused omentum, 
the risk of  peri- and postoperative bleeding will be lower. An interesting histological 
feature found in the patch group was the formation of a well-organized and vascularized 
collagen layer on top of the perforation. Kung describes this observation as an outer 
shield formed by !brosis on top of a Te"on-felt graft, which was tested in dogs 12. 
Whether this has any clinical importance remains unclear, but it might lower the risk of 
leakage or recurrence of the perforation. No approval from the animal ethical 
committee was given for a control group in which the spontaneous sealing of a 
perforation by liver or omentum could have been investigated. It is estimated that 
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about 40% of the perforations in humans, with an average size of 5 mm, seal by 
themselves 16. The perforation made in our rat model had a diameter of 5 mm which 
would be comparable to a giant ulcer in a human stomach. Spontaneous healing of a 
giant ulcer is less likely to happen and associated with high morbidity and mortality 17.  
Conclusion
The closure of a perforated peptic ulcer by using a biodegradable patch is feasible. It 
might even have advantages, such as less adhesion formation, lower recurrence rate 
and less hematoma formation. The lactide-glycolide-caprolacton patch has proven to 
be resistant to gastric acid. Also the biodegradation process did not go too fast; the 
patch material started disappearing after the perforation was healed, but also didn’t 
stay too long. After 10 weeks, the material microscopically was almost completely 
degraded. This makes the material suitable for other parts of the digestive tract.  That’s 
why the stamp method might be an interesting method to close small bowel 
perforations. Realizing that the stamp method has not been tested on a real perforated 
peptic ulcer with associated peritonitis and also needs to be tested laparoscopically, 
further research will be interesting and necessary. 
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Helicobac ter  genot yping 
and detec tion in  p erop erative 
lavage f luid in  patients  with 
Per forated Peptic  Ulcer
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Abstract 
Background  Certain Helicobacter pylori genotypes are associated with peptic ulcer 
disease; however, little is known about associations between the H. pylori genotype 
and perforated peptic ulcer (PPU). The primary aim of this study was to evaluate which 
genotypes are present in patients with PPU and which genotype is dominant in this 
population. The secondary aim was to study the possibility of determining the 
H. pylori status in a way other than by biopsy. 
Methods  Serum samples, gastric tissue biopsies, lavage "uid, and "uid from the 
nasogastric tube were collected from patients operated upon for PPU. By means of 
PCR, DEIA, and LIPA the presence of the “cytotoxin associated gene” (cagA) and the 
genotype of the “vacuolating cytotoxin gene” were determined. 
Results  Fluid from the nasogastric tube was obtained from 25 patients, lavage "uid 
from 26 patients, serum samples from 20 patients and biopsies from 18 patients. 
Several genotypes were found, of which the vacA s1 cagA positive strains were 
predominant. Additionally, a correlation was found between the H. pylori presence in 
biopsy and its presence in lavage "uid (p=0.015), rendering the latter as an alternative 
for biopsy. Sensitivity and speci!city of lavage "uid analysis were 100% and 67%, 
respectively. 
Conclusion  This study shows the vacA s1 cagA positive strain is predominant in a PPU 
population. The correlation found between the H. pylori presence in biopsy and its 
presence in lavage "uid suggests that analysis of the lavage "uid is su$cient to 
determine the H. pylori presence. Risks associated with biopsy taking may be 
avoided. 
Introduction
Over the past decades the incidence of perforated peptic ulcer (PPU) has declined in 
the western world. However, with an incidence varying between two and 10 per 
100.000, it still is a problem in modern society 1. Moreover, mortality rates caused by 
gastric and duodenal ulcer perforation vary between 10 and 40% and zero and 10% 
respectively, and is higher among elderly patients 2, 3. Several risk factors for PPU have 
been described like smoking, alcohol abuse, and history of peptic ulcer disease (PUD) 2. 
However the main pathogenic factors are considered to be the use of non-steroidal 
anti-in"ammatory drugs (NSAID) and the presence of H. pylori 2. 
Helicobacter pylori are widespread bacteria, with a prevalence ranging from 25% in 
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the industrialized world to more than 70% in developing countries 4, 5. Most infected 
people remain asymptomatic; however, a small group of carriers will develop PUD. 
Of patients who have developed PPU, 70% will test positive for H. pylori 2, suggesting 
the pathogenesis of perforation is associated with the presence of H. pylori. In 
addition, it is shown that di#erent genotypes of H. pylori are associated with di#erent 
clinical manifestations like PUD and gastric cancer 6, 7. Two well-known H. pylori genes 
that have been associated with PUD are the cytotoxin-associated gene (cagA) and the 
vacuolating cytotoxin gene (vacA) 6, 8-10. 
VacA is present in all H. pylori strains and is associated with gastritis, PUD and gastric 
carcinoma 10-12. It encodes for a vacuolating cytotoxin that causes epithelial cell injury 
and interferes with the immune system 13, 14. VacA contains at least two variable 
regions, the signal peptide (s)-region and the middle (m)-region. The s-region contains 
two allelic types, s1 and s2. The s1 strain has several subtypes, being s1a, s1b and s1c 15. 
Two allelic types exist for the m-region, m1 and m2. The latter has two subtypes, m2a 
and m2b 16. CagA is considered a marker for a genomic pathogenicity (cag) island that 
is associated with enhanced virulence 17. 
If PPU is associated with a speci!c H. pylori genotype it may be feasible to limit the 
patients undergoing antibiotic therapy to those who have this genotype. When this 
speci!c type is not present, another cause of PPU should be looked for and antibiotic 
therapy should not be started. This would mean cost reduction and, probably, a 
reduction in the development of antibiotic resistance. 
Currently, gastric biopsy during endoscopy is a generally accepted method to 
diagnose H. pylori infection. However, patients with PPU will not undergo endoscopy 
but will generally be operated upon immediately. Taking a biopsy intraoperatively 
implicates a higher risk of bleeding and more di$cult closure of the defect.  Therefore, 
surgeons are reluctant to take a biopsy. The primary aim of this study was to evaluate 
which genotypes are present in patients with PPU and if a genotype is dominant in 
this population. The secondary aim was to study the possibility of determining the 
H. pylori status in a fashion other than by gastric tissue biopsy.
Methods
From 30 consecutive patients operated upon for PPU serum samples, gastric tissue 
biopsies, lavage "uid and "uid from the nasogastric tube were collected. These 
patients were treated in !ve di#erent medical centers throughout the Netherlands. In 
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each of these centers approval of the medical ethical committee was obtained. 
Immediately after collection, the materials were frozen at –20°C. One researcher 
performed the analysis and genotyping. For H. pylori genotyping, the presence of 
cytotoxin-associated gene (cagA) and the s- and m-region genotypes of the 
vacuolating cytotoxin gene (vacA), were determined.
DNA was isolated according to Boom’s method as described previously 18.  A guanidine 
thiocyanate (GuSCN) solution was added to the collected material to induce lysis of 
the bacteria, releasing their DNA. After addition of the silica particles (Celite) the 
suspension was centrifuged. The silica particles, with the attached DNA, were washed 
with subsequently GuSCN-containing washing bu#er, ethanol 70 % and acetone. After 
drying, the DNA was eluted in an aqueous low salt bu#er. The isolated DNA was 
ampli!ed by means of polymerase chain reaction (PCR) and subsequently the 
presence of cagA and di#erent types of vacA were analyzed by means of reverse 
hybridization on a strip (32). This assay consists of a nitrocellulose strip that contains 
dT-tailed oligonucleotide probes immobilized as parallel lines. For each strain, 10 µl of 
each PCR product (containing biotin at the 5’ end of each primer) was denatured by 
the addition of an equal amount of 400 mM NaOH–10 mM EDTA in a plastic trough. 
After 5 min, 1 ml of prewarmed hybridization solution (2x SSC [1x SSC is 0.15 M NaCl 
plus 0.015 M sodium citrate], 50 mM Tris-HCl [pH 7.5], 0.1% SDS) was added, and a 
strip was submerged and incubated in a shaking water bath at 50°C for 1 h. The strips 
were washed with 2 ml of 2x SSC–0.1% SDS for 30 min at 50°C. Subsequently, the 
strips were rinsed three times in phosphate bu#er, and conjugate (streptavidin-
alkaline phosphatase) was added. After incubation at room temperature for 30 min, 
the strips were rinsed again and 4-nitroblue tetrazolium chloride and 5-bromo- 4-
chloro-3-indolylphosphate substrate was added. Hybrids are visible as purple probe 
lines. Interpretation of the hybridization patterns was performed visually. As a control 
a β-globin PCR was performed. Patient related factors were obtained prospectively. 
Statistical analysis was performed with SPSS for Windows, version 11.0.
Results
A total of 30 patients were included of whom nine were women. The average age was 
65 years, varying between 40 and 87. Ten patients (33.3%) were operated 
laparoscopically. The perforation was found prepyloric in 11 patients, at the site of the 
pylorus in eight patients and postpyloric in 11 patients. A total of !ve (16.7%) patients
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Table 1.  H. pylori status and genotype. 
The colors represent the ß-globin and H. pylori status of the patient.
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had a history of PUD. Ten patients (33.3%) used NSAIDs, two patients (6.7%) used 
steroids, three patients (10.0%) used acid reducers and one patient (3.3%) used a 
proton pump inhibitor (PPI) before admission to the hospital. The average hospital 
stay was 11.9 days, varying between 3 and 37 days. Fluid from the nasogastric tube 
was obtained from 25 patients, lavage "uid from 26 patients, serum samples from 20 
patients and ulcer biopsies from 18 patients. The results of the genotyping are 
depicted in Table 1. The ß-globin determination was performed as a control. In nine 
samples of nasogastric tube "uid and in two samples of lavage "uid it was negative, 
rendering these results as unreliable. Therefore these results were excluded from 
further analysis. Table 2 represents the frequency of the individual genes, the allelic 
types and subtypes found in the di#erent samples by means of PCR and LiPA. These 
tables show that for vacA the allelic type s1 is predominantly present in all three types 
of samples. In the s1 positive strains, subtype s1a is predominant as depicted in table 
3.  With regard to the middle region of vacA the incidence of m1 allelic type is slightly 
higher; however the di#erence is less outspoken compared to s1. The m2a was the 
only subtype that was found in the samples. In three samples, the genotyping was 
incomplete (Table 1 and 2), meaning that determination of the middle region was not 
possible. This was most likely caused by the small number of bacteria present in those 
samples. With regard to the secondary aim of this study, analyzing possibilities to 
diagnose H. pylori presence in another fashion than through biopsy, the H. pylori 
status found in each type of sample was compared.  A correlation was found between 
the H. pylori presence in biopsy and its presence in lavage "uid (Fisher’s exact test, 
p=0.015), indicating lavage "uid is a valid alternative for determination of H. pylori 
infection. The sensitivity and speci!city of the lavage "uid analysis was calculated, 
considering biopsy as a golden standard. Fourteen patients, of which the lavage "uid 
as well as the biopsy were analyzed, were included into this calculation (patients 
2,4,5,6,8,10,15,23-25,27-30, Table 1), which is shown in Table 4. Of the remaining 
patients, either the biopsy or the lavage "uid was missing; therefore, these data cannot 
be used in the sensitivity/ speci!city calculation. The sensitivity was 100 %, which 
means that in case of presence of H. pylori in the biopsy specimen, the lavage "uid 
analysis detected it in 100% of cases.  The speci!city was 66.7%, which means the 
chance for false-positives is over 30%. With regard to gender, age, BMI, history of PUD, 
location of perforation, complications after procedure and use of steroids, PPI, or 
antihistaminic medication, no statistically signi!cant correlation was found.
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Table 2.  Frequencies of individual genes, allelic types and subtypes. “VacA multiple” means 
that more than one allelic type or subtype have been found in one sample. In each di#erent 
type of sample one incomplete genotype occurred, which is indicated as “vacA incomplete”. 
The “Control non ulcer” column represents the frequencies, found by van Doorn et al., in a 
population without PUD and is added to allow easy comparison.
 Fluid from     
 naso-gastric    Gastric  Control 
Genotype tube  Lavage "uid  tissue biopsy non-ulcer
 no % no % no % %
vacA s1 10 90.9 14 77.8 7 77.8 46.9
vacA s2 0 0 1 5.5 1 11.1 38.4
vacA multiple 1 9.1 3 16.7 1 11.1 14.7
Total 11 100 18 100 9 100 100
vacA m1 6 54.5 9 50.0 5 55.6 29.4
vacA m2 4 36.4 8 44.4 3 33.3 55.9
vacA incomplete 1 9.1 1 5.6 1 11.1 0 (14.7 % 
genotype       incomplete)
Total 11 100 18 100 9 100 100
cagA positive 9 81.8 14 77.8 5 55.6 47.1
Total 11 100 18 100 9 100 100
Table 3.  Distribution of the vacA s1 subtypes. 
The s1a subtype is predominant in all types of samples. The “Control non ulcer” column 
represents the frequencies, found by van Doorn et al., in a population without PUD and is 
added to allow easy comparison.
 Fluid from     
 naso-gastric    Gastric  Control 
VacA Subtype tube  Lavage "uid  tissue biopsy non-ulcer
 no % no % no % %
s1a 8 80.0 13 92.9 5 71.4 81.3
s1b 2 20.0 1 7.1 2 28.6 18.7
s1c 0 0 0 0 0 0 0
Total 10 100 14 100 7 100 100
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Discussion
Concerning the role of H. pylori in the pathogenesis of PPU, some studies have been 
reported comparing the prevalence of H. pylori infection in patients with PPU with 
the prevalence in controls. They appear to be similar suggesting that other factors like 
NSAID use play a role 19-21.  However, the substantial genetic heterogeneity of H. pylori 
that has been revealed over the years leads to the hypothesis of a speci!c genotype 
causing PPU 5. Controls might test positive for H. pylori, but not develop PPU because 
it would not be this speci!c genotype that is isolated. This study of a selected 
population of patients, all with PPU, shows a limited diversity of H. pylori genotypes as 
represented by Table 1. 
VacA s1 strains are predominantly present in the three sample types of which s1a is 
the predominant subtype. Concerning the vacA m-region, the m1 strains are found in 
a majority of cases, however, the di#erence is less convincing than for vacA s1. Except 
for the biopsy samples, the cagA positive strains were predominantly present in this 
population. In the biopsy samples, the frequency of cagA positive strains seemed to 
be low, however this number is distorted because in two of nine positive biopsies, a 
decent comparison with the other samples was not possible. In patient 5, genotyping 
of the lavage "uid and nasogastric tube "uid was incomplete and for patient 15, the 
opposite was the case. This means that the actual incidence should be 71.4% (5/7). 
Summarizing, these results show that the vacA s1, cagA positive strains were 
predominant in this population of patients with PPU. This !nding is in accordance 
with literature reporting correlations between the presence of vacA s1, cagA positive 
strains and PUD 6, 10. Therefore, detection of the genotype vacA s1 does not speci!cally 
predict PPU; nevertheless, clinicians should be aware of this association. 
In Tables 2 and 3 the genetic distribution in a Dutch population without PUD, as found 
Table 4.  Calculation of sensitivity and speci"city of lavage !uid analysis, considering the biopsy 
to be the golden standard
 Biopsy
Lavage "uid  + - Total
 + 8 2 10
 - 0 4 4
 Total 8 6 14
  Sens 8/8 = 1  Spec 4/6 = 0.67
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by van Doorn et al., are added for comparison. The frequencies found in this study for 
vacA s1, m1 and cagA positive strains are clearly higher than in the non-PUD group, 
con!rming the before mentioned hypothesis. However, with regard to the subtypes, 
Table 3 shows an almost similar distribution of frequencies, suggesting that 
determination of the allelic subtype is of less importance.
In only 60% of patients biopsies could be analyzed. Reasons for missing 40% is the 
restraint of the surgeon to take a biopsy when risk of bleeding and more di$cult 
closure of the defect was estimated to be too high, which emphasizes the importance 
of !nding an alternative. To do so, the H. pylori status of the patient as determined by 
biopsy was compared to the status as determined by analysis of nasogastric tube 
"uid, lavage "uid, and serum. A statistically signi!cant correlation was found between 
the H. pylori status in biopsy and its status in lavage "uid (Fisher’s exact test, p=0.015). 
This !nding suggests that determination of the H. pylori status can be done with 
lavage "uid as well, obviously without any risk of bleeding and closure related 
di$culties. The sensitivity is 100%, but the speci!city is 66.7%. This could mean the 
chance for false-positives is over 30 %, which is not optimal and could lead to therapy 
overshoot. However, considering the fact that with the lavage a larger area is sampled, 
rendering the chance of positive test results higher than in biopsy, it is more likely to 
!nd false negative biopsy results. This could lead to a therapy undershoot, which 
obviates the importance having an alternative for a biopsy.
In only two samples, both nasogastric tube "uids, a H. pylori genotype was isolated, 
while β-globin tested negative. In nine samples (seven nasogastric tube "uid, two 
lavage "uid) both β-globin and H. pylori tested negative. This means that either no 
humane cells were present in the samples, which is unlikely, or that an error in the PCR 
procedure had occurred. Because this was unclear these results were considered 
unreliable. Therefore, it still could be possible that nasogastric tube "uid is a good 
alternative for determining the H. pylori status as well.  
Overall, these results are positive, however they should be con!rmed in a larger 
population. 
Conclusion
This study shows that in a population of 30 patients with PPU, vacA s1, cagA positive 
strains are predominant. This !nding is in accordance with literature reporting 
correlations between the presence of vacA s1, cagA positive strains and PUD. Therefore 
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detection of this genotype does not speci!cally predict PPU. Nevertheless, clinicians 
should be aware of this association. 
This study shows as well that it is feasible to use intraoperative lavage "uid to 
determine the H. pylori status of the patient, implicating that biopsies, with a risk of 
bleeding and more di$cult closure of the defect, are not necessary anymore. In 
addition, considering the fact that a larger area is sampled with lavaging, biopsies 
may result in more false negative results leading to insu$cient therapy.
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Summary
Chapter 1
It al started with the LAMA trial, a Dutch multicentre trial, in which the laparoscopic 
suturing of a perforated peptic ulcer was compared with suturing by upper laparotomy, 
at that time !rst treatment of choice. During this trial questions raised about general 
operation techniques considering this procedure, alternative suturing techniques, 
screening methods for Helicobacter pylori and which routine steps to take in the pre- 
and postoperative phase. In this thesis a review is given about all decisions and steps 
needed to be taken if a patient presents with acute abdominal pain, suspected for a 
perforated peptic ulcer.
Chapter 2
Stress is often mentioned as being responsible for the emergence of a perforated 
peptic ulcer, but PPU is not a typical phenomenon of nowadays- stressful lifestyles. 
Already in 1600 the clinical symptoms were described, but still up to now this acute 
disease is associated with high morbidity and mortality. The article in chapter 2 gives 
an overview of the epidemiology throughout the centuries, underlying pathology, 
possible treatment options (conservative versus surgical) and the surgical techniques 
for management of the perforation. 
Chapter 3
During the 80s laparoscopic surgery became more popular. It was possible to remove 
a gallbladder laparoscopically with good results, less postoperative pain and fewer 
complications. Since, several articles (mainly retrospective) have been published 
about laparoscopic suturing of a perforated peptic ulcer, but unfortunately this 
procedure still not is !rst method of choice. All publications regarding this topic have 
been evaluated according to the E#ective Public Health Practice Project guidelines. 
Concluding, there are several convincing arguments for treating patient, suspected 
for having a perforated peptic ulcer laparoscopically. Relative contra-indications are a 
Boey score of 3, patients over 70 years old and symptoms existing for more than 24 
hours. 
Chapter 4
This chapter reports the results of a randomized trial, started in the Netherlands in 
1999, in which nine hospitals participated. A total of 101 patients were randomized, of 
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which 52 were treated by laparoscopic surgery and 49 patients received an upper 
laparotomy. Results show that the laparoscopic procedure takes longer surgery time, 
but patients in this group had less postoperative pain. Concluding laparoscopic 
closure of perforated peptic ulcer was a safe procedure.
Chapter 5
To get an impression about the golden standard in Europe a questionnaire was sent 
to all members considering their routine procedures according the treatment of PPU 
in collaboration with the European Association of Endoscopic Surgery (EAES) 
The results of 540 completed questionnaires were evaluated and summarized. One of 
the outstanding results was that, unlike a few years ago, laparoscopic correction of a 
PPU is !rst method of choice nowadays. Also the incidence of PPU, despite adequate 
anti ulcer therapy seems not to have declined. Due to the fact that many surgeons, 
especially the experienced ones, start surgery laparoscopically as a diagnostic tool, 
the necessity of performing a CT scan preoperatively has diminished. 
Chapter 6
During meetings with the surgeons participating in the LAMA trial, several times it 
was mentioned that the laparoscopically positioning and tying of the sutures was a 
di$cult and time consuming part of the procedure, with the risk of tearing out of 
the sutures and the possibility of enlarging the perforation hole.  
Because of this, an alternative method was thought of ,avoiding the suturing process. 
A biodegradable patch, consisting of lactide-glycolide-caprolactone was made, which 
could be glued like a ‘stamp’ on the outside of the stomach, covering the perforation 
site. The method was tested on animals and the results showed that the rats had no 
adverse side e#ects of the material, there were no postoperative complications and 
histological no sign of rejection.
Chapter 7
Because of the positive results of the pilot study with the ‘stamp’ method a randomized 
trial was started in rats, comparing the patch method with the conventional method 
for closing a perforated gastric perforation by suturing the perforation with a Graham 
patch. Histological the healing process was observed with a follow-up of ten 
consecutive weeks. The healing process of the stomach wall was observed as well as 
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any adverse e#ects due to the lactide-glycolide-caprolactone. There were no 
postoperative complications. Histological giant cells started degradation of the patch 
at week 2. There were no signs of rejection. The mucosal layer was closed after 2 weeks, 
the muscular layer after 8 weeks. Both methods were comparable.  
Chapter 8
Since the discovery of the role of Helicobacter pylori in the emergence of peptic ulcer 
disease in 1982 by Barry J. Marshall en Robin Warren, many patients are prophylactic 
treated with antibiotics, to prevent occurrence of complications like perforations. It is 
known that Helicobacter has di#erent genotypes, which not all are responsible for 
causing symptoms and because of this not all carriers need prophylactic treatment. In 
this study, material was collected from patients who had surgery for PPU. The material 
was tested for Helicobacter and DNA typing was done if Helicobacter was present. It 
appeared to be possible to test Helicobacter from abdominal irrigation "uid, making a 
biopsy from the stomach wall unnecessary. Several genotypes were found, of which 
vacAs1cagA was dominant.
‘ Future perspectives’
According to the review articles from chapter 2 and 3 there are still many controversies 
according the treatment for perforated peptic ulcer disease. Research addressing for 
example the necessity of the omental patch, the need for thorough irrigation of the 
abdominal cavity or the bene!ts of using abdominal drains might be useful in 
establishing consensus on surgery for perforated peptic ulcers. 
One of the great advances of laparoscopic surgery, besides less operative pain and 
complications on the short term, probably is less intra-abdominal adhesion formation. 
In literature, it is not known if this is the case in PPU.
The ‘stamp method’ has proven that it is possible to close a perforation of the stomach 
with a bioabsorbable patch. The material can resist the acid environment and it does 
not cause any side e#ects.  Because of this, very likely the patch can be used for other 
perforations as well, like bowel perforations and it would be interesting to know if for 
instance a bowel resection could be avoided by using the patch. Also the patch could 
be used for protecting newly made anastomoses or prevent leakage. It could be used 
for treatment of a cervical esophageal anastomotic complications and making a 
myocutaneous "ap redundant
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Samenvatting
Hoofdstuk 1
Het is allemaal met de LAMA trial begonnen, een Nederlandse multicenter trial waarin 
het laparoscopisch overhechten van een maagperforatie werd vergeleken met de op 
dat moment gangbare standaard techniek i.e. het overhechten door middel van een 
bovenbuiklaparotomie. Tijdens deze studie werden er vragen opgeroepen over 
algemene operatietechnieken en alternatieve hechttechnieken, screeningsmethodes 
voor Helicobacter pylori en over het te volgen pre-, per en postoperatieve beleid. In 
dit proefschrift is geprobeerd een overzicht te geven over het hele traject en keuzes 
die gemaakt moeten worden met betrekking tot een patiënt die zich presenteert met 
een acute buik, verdacht voor een maagperforatie.
Hoofdstuk 2 
Een maagperforatie wordt, zoals men lang dacht vaak veroorzaakt door stress, maar is 
echter geen typisch verschijnsel van de huidige stressvolle tijd. Het klinisch beeld 
werd immers al in 1600 beschreven, maar tot op heden is deze acute aandoening nog 
steeds geassocieerd met een hoge morbiditeit en mortaliteit. Dit artikel geeft een 
overzicht van de epidemiologie door de jaren heen, de pathologie en mogelijke 
behandelingen (conservatief versus operatief ) en chirurgische technieken om de 
perforatie te behandelen. 
Hoofdstuk  3
In de jaren 80 werd het laparoscopisch opereren steeds meer populair. Het bleek dat 
het laparoscopisch mogelijk was om een galblaas te verwijderen met goede resultaten, 
minder postoperatieve pijn en minder complicaties. Sindsdien zijn er ook verschillende 
(met name retrospectieve) studies gepubliceerd over het laparoscopisch overhechten 
van een maagperforatie, maar helaas is deze ingreep meestal nog geen eerste keus 
van behandeling.  Met behulp van de E#ective Public Health Practice Project richtlijnen 
zijn deze publicaties geëvalueerd. Concluderend blijken er genoeg argumenten te 
zijn om bij een patiënt verdacht voor maagperforatie, laparoscopisch de 
maagperforatie te sluiten. Relatieve contra-indicaties zijn een Boey score van 3, een 
patiënt ouder dan 70 jaar en indien de symptomen al langer dan 24 uur bestaan. 
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Hoofdstuk 4
Dit hoofdstuk beschrijft de resultaten van een gerandomiseerde studie, gestart in 
1999 in negen ziekenhuizen in Nederland. 101 patiënten werden gerandomiseerd, 
waarvan 52 laparoscopisch werden geopereerd en 49 door middel van een 
bovenbuiklaparotomie. De resultaten lieten zien dat de laparoscopische ingreep 
langer duurde, maar de patiënten uit deze groep hadden minder postoperatieve pijn. 
Samenvattend bleek het laparoscopisch overhechten van een maagperforatie een 
veilige ingreep.
Hoofdstuk 5
Om een indruk te krijgen over het huidige beleid in Europa, is met behulp van de 
European Association of Endoscopic Surgery (EAES) een enquête over het 
laparoscopisch hechten van PPU rondgestuurd. Resultaten werden berekend op 
grond van 540 compleet ingevulde enquêtes.  Opvallende uitkomsten zijn, dat in 
tegenstelling tot enkele jaren geleden het laparoscopisch overhechten van  PPU nu 
de eerste keus van behandeling is en dat de incidentie van PPU, ondanks adequate 
anti-ulcer medicatie, niet lijkt te zijn afgenomen . Tevens lijkt het starten met behulp 
van diagnostische laparoscopie, zeker bij ervaren chirurgen de noodzaak tot het 
preoperatief maken van een CT scan te doen afnemen. 
Hoofdstuk 6
Tijdens besprekingen met de participerende chirurgen van de LAMA trial kwam ter 
sprake dat het laparoscopisch overhechten van een maagperforatie een lastig 
onderdeel van de ingreep was, met als risico uitscheuren van de hechtingen, waardoor 
mogelijk kans op vergroten van de perforatie. Derhalve werd gezocht naar een 
alternatief voor de hechtprocedure, te weten het plakken van een bioafbreekbare 
‘postzegel’ (patch van lactide-glycolide-caprolactone) op de buitenzijde van de maag, 
welke de perforatie zou bedekken. Deze methode werd dier experimenteel getest. 
Het bleek dat het materiaal goed door de ratten werd verdragen, er waren 
postoperatief geen complicaties en histologisch ook geen tekenen van afstoting.
Hoofdstuk 7
Daar de pilotstudy van de “postzegelmethode” succesvol was, werd aanvullend een 
gerandomiseerde studie bij ratten verricht waarin de stamp methode werd vergeleken 
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met het overhechten van de maagperforatie op de conventionele manier via het 
gebruik van een Graham patch. Tevens werd het genezingsproces histologisch 
bekeken, met een follow-up van tien op één volgende weken. Beoordeeld werd hoe 
de maagwand ter plaatste van de perforatie herstelde en wat het e#ect was van de 
lactide-glycolide-caprolactone. Er traden geen postoperatieve complicaties op. 
Histologisch werd gezien dat de afbraak van de patch door reuscellen na 2 weken 
werd gestart. Er waren geen afstoting reacties. De mucosa was na 2 weken gesloten 
en de spierlaag na 8 weken.  Beide methodes waren vergelijkbaar. 
Hoofdstuk 8
Sinds de ontdekking van de rol van Helicobacter pylori bij het ontstaan van peptic 
ulcer disease in 1982 door Barry J. Marshall en Robin Warren, worden veel patiënten 
profylactisch behandeld met antibiotica, ter voorkoming van complicaties zoals 
perforatie. Het is inmiddels gebleken dat Helicobacter verschillende genotypes heeft, 
welke niet allemaal ziekteverschijnselen veroorzaken en dus behandeld behoeven te 
worden. In deze studie is materiaal van patiënten verzameld, welke geopereerd 
werden in verband met een maagperforatie. Dit materiaal werd onderzocht op 
aanwezigheid van Helicobacter pylori en hiervan werd DNA typering gedaan. Uit de 
studie bleek dat Helicobacter kon worden bepaald in buikspoelvloeistof en dat een 
biopt van de plaats van perforatie onnodig bleek. Er werden verschillende genotypen 
gevonden, waarvan de vacAs1cagA variant dominant aanwezig was.
Toekomstig onderzoek
Uit de review artikelen van hoofdstuk 2 en 3 blijkt dat er nog heel wat discussie punten 
bestaan over de juiste behandeling van een maagperforatie. Gerichte studies naar 
bijvoorbeeld de zin of onzin van een omentumpatch, het wel of niet uitgebreid 
spoelen van een buik of het gebruik van drains zouden een waardevolle bijdrage 
kunnen leveren tot de vorming van een consensus.
Een groot voordeel van laparoscopisch opereren, naast het optreden van minder 
postoperatieve pijn en complicaties op korte termijn, zou kunnen zijn dat er minder 
intra-abdominale adhesies optreden.  In de literatuur is hier bij maagperforaties nog 
weinig over bekend. 
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De ‘stamp method’ heeft aangetoond dat het gebruik van een bioafbreekbare patch 
bij een maagperforatie mogelijk is. Het materiaal is bestand tegen de lage pH van de 
maag en geeft geen afstotingsreacties.  Dit maakt het zeer waarschijnlijk dat de patch 
ook bruikbaar is bij andere perforaties, zoals bijvoorbeeld bij darmperforaties en het 
zou interessant zijn om dierexperimenteel uit te zoeken of dit bijvoorbeeld een 
darmresectie kan voorkomen. Tevens zou dit materiaal gebruikt kunnen worden als 
een beschermlaag rondom anastomoses in de tractus digestivus om de kans op 
lekkage te verkleinen of zelfs als behandeling kunnen dienen bij een naadlekkage van 
een slokdarmanastomose, waarbij de noodzaak voor een huid-spierlap misschien 
onnodig blijkt.
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